Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3012110	s-lzm	mg/l (mg/l)	11381	24207	0.02%
3012110	s-lzm	— (—)	1155	1323	100.00%	Distribution not available
3012110	s-lzm	mg/l______ (mg/l)	261	480	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Acute and subacute iridocyclitis

871

2134

4.40

323.31

2.4

2.1

10.62

11.66

mg/l

2.88

835

1985

Other arthritis (FG)

1138

3371

3.55

317.86

1.9

2.2

11.37

11.12

mg/l

0.41

1065

3172

Bacterial infection, other or unspecified, including avohilmo

1849

5741

2.73

317.73

1.8

2.1

13.69

11.23

mg/l

16.79

1707

5378

Cardiac arrhythmias

1845

4319

2.83

317.73

2.8

2.0

10.97

10.44

mg/l

1.72

1730

4104

Pacemaker

1235

3542

3.40

317.02

3.4

1.7

11.01

12.67

mg/l

7.59

1172

3259

All-cause Heart Failure

1782

4537

2.84

314.09

2.1

1.9

13.31

11.85

mg/l

4.11

1659

4212

All chronic kidney diseases

1745

5145

2.80

312.36

2.4

1.9

16.31

10.76

mg/l

42.69

1612

4814

Bacterial infection, other or unspecified

1707

5320

2.81

310.54

1.9

2.0

13.82

11.34

mg/l

15.14

1577

4980

Other respiratory diseases principally affecting the interstitium

765

1757

4.69

308.49

1.8

1.9

11.82

12.64

mg/l

1.05

717

1617

Cardiomyopathy (excluding other)

583

1064

5.98

308.32

2.1

1.7

11.20

11.53

mg/l

0.40

539

991

Other heart diseases

1798

3059

4.00

307.65

3.0

2.0

11.81

10.00

mg/l

10.23

1701

2915

Fever of other and unknown origin

2187

4972

3.99

307.65

2.0

12.11

11.09

mg/l

4.67

2057

4676

Renal failure

1584

4562

3.08

307.65

2.3

1.8

17.16

11.19

mg/l

62.87

1460

4233

L04AX Other immunosuppressants

2155

7138

3.17

307.65

2.8

2.0

11.24

11.35

mg/l

0.24

2029

6704

ILD medications

4361

6174

3.98

307.65

2.8

1.5

11.60

11.08

mg/l

2.40

4126

5783

Diagnoses used for exclusion with ILD

2712

2469

13.67

307.65

5.1

1.3

11.53

12.18

mg/l

1.40

2637

2276

Other heart diseases, wide

3012

6638

2.84

307.65

2.6

2.0

11.64

10.81

mg/l

3.15

2834

6266

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

597

437

10.58

307.65

1.9

2.1

11.49

11.28

mg/l

0.18

562

414

ILD medications: prednisolone, methylprednisolone, prednisone

4331

6098

4.13

307.65

2.9

1.5

11.58

11.10

mg/l

2.08

4090

5711

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3115

6569

4.40

307.65

2.8

1.8

11.79

11.70

mg/l

0.19

2965

6095

Heart failure and antihypertensive medication

1060

1394

5.28

307.65

2.5

1.9

12.72

10.50

mg/l

4.33

1001

1305

Inflammatory bowel disease treatment related agents

4410

6922

3.69

307.65

2.9

1.5

11.35

mg/l

0.01

4166

6493

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4863

6862

5.09

307.65

3.4

1.2

12.11

10.83

mg/l

13.20

4610

6418

Anterior Iridocyclitis

932

2295

4.39

307.65

2.5

2.1

10.68

11.67

mg/l

2.83

893

2141

Iridocyclitis

1062

2588

4.43

307.65

2.5

2.1

10.99

11.65

mg/l

1.64

1022

2402

ILD differential diagnosis

2087

3213

3.35

307.65

2.5

1.2

11.69

10.92

mg/l

2.55

1962

3000

Certain disorders involving the immune mechanism

2850

1814

22.74

307.65

5.0

1.2

11.67

11.52

mg/l

0.22

2772

1680

ILD medications: immunosuppressive drugs

2650

5669

4.47

307.65

2.7

1.5

11.66

10.95

mg/l

3.11

2498

5319

Asthma (only as main-diagnosis)

2124

3187

3.85

307.65

2.3

1.2

10.90

10.91

mg/l

0.02

2018

2976

Second line medication for Crohn's disease

2197

7332

3.14

307.65

2.8

2.0

11.20

11.32

mg/l

0.27

2069

6886

Other pulmonary diagnosis

1915

3215

3.06

307.65

2.0

1.2

11.72

10.92

mg/l

2.46

1796

3002

Cough

1343

3982

3.27

307.65

2.4

2.0

11.46

11.53

mg/l

0.11

1258

3719

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

482

689

7.99

307.65

1.7

2.0

12.43

12.31

mg/l

0.07

442

628

Oral corticosteroids

4351

6772

3.95

307.65

2.9

1.6

11.32

11.36

mg/l

0.09

4101

6349

Asthma (mode)

2256

3213

3.81

307.65

2.3

1.2

10.83

10.92

mg/l

0.19

2140

3000

Asthma

2292

3187

3.83

307.65

2.2

1.2

10.81

10.91

mg/l

0.21

2172

2976

Asthma, unspecified (mode)

1699

3024

4.21

307.65

2.3

1.2

10.90

10.95

mg/l

0.07

1601

2823

Enlarged lymph nodes

1180

1367

9.92

307.65

3.3

1.9

12.19

10.99

mg/l

2.60

1137

1284

Heart failure, not strict

2461

5900

2.92

307.65

2.4

2.0

13.41

10.92

mg/l

17.56

2304

5531

Cardiomyopathies, Primary/intrinsic

576

991

6.36

307.65

2.2

1.7

11.13

11.64

mg/l

0.71

532

927

Other systemic involvement of connective tissue (FG)

1015

2488

4.25

307.65

1.7

2.2

11.07

11.29

mg/l

0.34

945

2319

Chronic kidney disease

1124

3112

3.65

307.65

2.4

1.8

18.25

11.31

mg/l

53.91

1034

2882

Asthma, unspecified (mode), excluding more controls

1675

2665

4.68

307.65

2.4

1.2

10.91

10.77

mg/l

0.28

1580

2492

Asthma, excluding more controls

2235

2806

4.23

307.65

2.2

1.2

10.79

10.74

mg/l

0.11

2121

2624

Systemic connective tissue disorders

1447

4005

3.84

307.65

1.7

2.1

11.37

11.82

mg/l

1.03

1348

3721

Asthma (only as main-diagnosis), excluding more controls

2084

2806

4.25

307.65

2.3

1.2

10.84

10.74

mg/l

0.22

1980

2624

Autoimmune diseases excluding thyroid diseases

3121

6972

2.49

307.65

1.9

2.2

11.39

mg/l

0.00

2940

6556

Excluding asthma or asthma-COPD overlap

2101

3215

3.37

307.65

2.5

1.2

11.68

10.92

mg/l

2.52

1975

3002

Sarcoidosis

2486

1199

35.33

307.65

5.4

1.2

11.54

11.69

mg/l

0.16

2428

1103

Cardiomyopathy

866

1482

6.39

307.65

2.7

1.7

11.48

11.45

mg/l

0.03

811

1383

Polyarthropathies

2263

5042

2.99

307.65

1.9

2.2

12.42

11.09

mg/l

5.37

2111

4760

COPD differential diagnosis

2087

3215

3.34

307.65

2.5

1.2

11.69

10.91

mg/l

2.57

1962

3002

Heart failure,strict

1753

3951

3.23

307.65

2.2

1.9

13.10

11.22

mg/l

6.39

1634

3682

Dyspnoea

2906

8379

2.58

307.65

2.2

2.1

11.60

11.39

mg/l

0.60

2738

7868

Abnormal findings on diagnostic imaging of lung

2518

4815

5.38

307.65

3.0

1.8

12.01

12.04

mg/l

0.04

2402

4448

Autoimmune diseases excluding thyroid diseases, strict definition

2997

6740

2.48

307.65

2.0

2.1

11.38

11.39

mg/l

0.02

2823

6330

Heart failure, strict

1841

4628

2.87

307.65

2.1

1.9

13.24

11.81

mg/l

4.09

1711

4298

Abnormalities of breathing

2790

5752

2.86

307.65

2.3

2.0

11.09

11.29

mg/l

0.52

2638

5412

General symptoms and signs

3227

5893

2.82

307.65

2.2

2.0

11.83

10.94

mg/l

3.76

3038

5557

First line medication for Crohn's disease

4031

6120

3.69

307.65

2.8

1.5

11.55

11.14

mg/l

1.59

3804

5745

Other interstitial pulmonary diseases

693

1478

5.10

307.09

1.9

2.0

11.61

12.69

mg/l

1.36

652

1363

Interstitial lung disease

693

1485

5.07

305.36

1.9

2.0

11.61

12.71

mg/l

1.39

652

1368

Interstitial lung disease endpoints

693

1485

5.07

305.36

1.9

2.0

11.61

12.71

mg/l

1.39

652

1368

Conduction disorders

1028

2244

3.85

305.26

3.4

1.8

11.86

11.50

mg/l

0.68

980

2087

Autoimmune diseases related-to ILD

2487

9230

2.31

303.41

1.8

2.2

11.36

11.40

mg/l

0.09

2334

8675

ILD, hospital admissions

686

1470

5.08

302.38

1.9

2.0

11.64

12.72

mg/l

1.35

647

1356

Disorders of sclera, cornea, iris and ciliary body

1812

7157

2.63

300.10

2.3

2.1

11.21

11.46

mg/l

0.67

1730

6699

Disorders of calcium metabolism

430

602

8.25

298.41

2.9

2.1

14.63

11.89

mg/l

3.88

385

559

Reimbursement for rheumatic diseases

1825

7238

2.60

295.16

1.7

2.2

11.14

11.46

mg/l

0.85

1712

6778

Other systemic involvement of connective tissue

1042

3070

3.59

294.43

1.8

2.1

11.13

11.73

mg/l

1.44

972

2849

Symptoms and signs involving the circulatory and respiratory systems

2636

5764

2.34

293.01

2.2

2.0

11.21

11.30

mg/l

0.19

2489

5424

Other specified/unspecified arthritis

1000

2880

3.65

291.95

1.9

2.1

11.36

11.14

mg/l

0.32

934

2714

ILD, hospital admissions 1, main diag only

632

1323

5.23

286.91

1.8

1.9

11.71

12.81

mg/l

1.24

599

1217

Other specific joint derangements/joint disorders

2132

5500

2.48

284.04

2.3

2.2

11.07

11.00

mg/l

0.16

1998

5190

Anaemias

724

945

5.12

282.60

2.0

2.1

12.86

9.89

mg/l

13.88

683

911

2490

6435

2.32

281.69

2.1

12.22

10.98

mg/l

5.53

2340

6085

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2490

6435

2.32

281.69

2.1

12.22

10.98

mg/l

5.53

2340

6085

Autoimmune diseases

2948

6994

2.18

280.38

2.0

2.2

11.40

11.39

mg/l

0.03

2782

6578

Other bacterial diseases

2693

8288

2.21

279.82

2.0

2.2

12.95

10.92

mg/l

18.87

2514

7811

Finngen Rheumatological endpoints

2622

6733

2.26

278.69

2.0

2.2

11.71

11.02

mg/l

2.04

2469

6356

Other bacterial diseases, including avohilmo

2847

8420

2.16

277.46

2.0

2.2

12.71

10.81

mg/l

18.42

2668

7942

Disorders of mineral metabolism

486

839

6.48

274.42

2.8

2.0

14.01

11.63

mg/l

3.98

437

782

Asthma (diagnoses ohter than nonallergic)

2523

9474

2.20

273.85

2.3

2.0

10.90

11.54

mg/l

3.64

2385

8885

Pain in joint

1783

4225

2.67

273.39

2.3

2.1

11.18

11.36

mg/l

0.43

1667

3986

AV-block

658

1218

4.88

269.08

3.8

1.6

11.73

11.96

mg/l

0.28

631

1114

Nonischemic cardiomyopathy

501

905

6.10

268.46

2.2

2.0

11.53

12.21

mg/l

0.73

467

836

All kidney diseases

2757

8818

2.14

268.11

2.3

2.1

13.97

10.43

mg/l

40.00

2566

8323

ILD medications: azathioprine

555

1106

5.35

264.64

4.2

1.5

12.06

10.98

mg/l

1.73

521

1029

Influenza and pneumonia

2927

8802

2.10

264.30

2.2

2.1

12.27

10.92

mg/l

7.36

2751

8299

Any gastric operation

1941

3877

2.56

261.09

2.1

11.83

10.41

mg/l

4.41

1822

3689

GASTRO-related operations

1941

3877

2.56

261.09

2.1

11.83

10.41

mg/l

4.41

1822

3689

Cardiovascular diseases (excluding rheumatic etc)

1719

3773

2.67

260.03

2.5

2.0

11.61

9.97

mg/l

8.21

1612

3598

Used for control exclusion in common control thyroid runs

2704

6392

2.18

254.75

2.0

2.2

11.30

11.41

mg/l

0.24

2556

6011

Pneumonia, organism unspecified

2570

8373

2.15

254.57

2.1

12.18

10.95

mg/l

8.45

2411

7889

Pneumonias (Asthma/COPD co-morbidities)

2794

8943

2.09

252.11

2.1

12.18

10.99

mg/l

6.08

2628

8429

Hypercalcemia

332

424

9.45

251.53

3.0

2.1

15.07

12.15

mg/l

4.44

299

393

All pneumoniae

2806

8960

2.08

250.94

2.1

12.18

10.99

mg/l

6.13

2640

8446

Other arrhythmias

1781

5502

2.48

249.15

2.6

2.0

10.85

10.97

mg/l

0.21

1668

5176

Pain in throat and chest

2173

5685

2.31

246.50

2.2

2.0

11.36

11.32

mg/l

0.07

2052

5346

Heart failure and coronary heart disease

1275

3115

2.98

245.88

2.2

1.9

12.94

12.22

mg/l

0.92

1192

2884

Renal tubulo-interstitial diseases

2420

8404

2.16

244.99

2.3

2.0

14.80

10.54

mg/l

44.89

2251

7909

Asthma, hospital admission 2, infections

1756

7310

2.41

243.16

2.2

2.1

11.24

11.64

mg/l

1.21

1660

6832

Asthma-related infections

1756

7310

2.41

243.16

2.2

2.1

11.24

11.64

mg/l

1.21

1660

6832

Headache

1712

5475

2.47

240.59

2.3

2.0

11.11

10.87

mg/l

0.52

1604

5160

ILD, hospital admission 2, with pulmonary infections

443

789

6.12

240.51

2.0

12.09

11.42

mg/l

0.68

415

726

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2720

9011

2.05

236.80

2.1

12.06

11.05

mg/l

6.91

2553

8496

Immunodeficiency with predominantly antibody defects

237

211

14.29

235.65

3.1

1.2

11.96

10.84

mg/l

0.87

229

195

Non-ischemic cardiomyopathy

997

2518

3.28

233.04

2.2

2.0

12.98

11.80

mg/l

3.15

918

2335

Azathioprine

555

1234

4.79

232.29

4.2

1.6

12.06

11.38

mg/l

0.79

521

1155

Percutaneous Coronary Intervention

2185

6075

2.25

231.82

2.6

2.1

11.79

11.49

mg/l

0.52

2067

5690

Dilated cardiomyopathy

536

1171

5.01

231.40

2.1

2.0

11.05

12.24

mg/l

2.19

497

1090

Cardiovascular diseases

1550

3142

2.68

230.68

2.3

1.9

11.40

9.93

mg/l

6.06

1457

2999

Adjustment and management of implanted device

658

1691

4.12

227.52

4.4

1.8

11.56

12.44

mg/l

1.23

633

1559

Malaise and fatigue

1362

4096

2.69

227.21

2.0

13.05

11.24

mg/l

4.47

1253

3836

Medical observation and evaluation for suspected diseases and conditions

1687

3450

2.56

226.68

2.2

2.0

12.01

10.81

mg/l

5.16

1576

3282

Examination and observation for other reasons

1558

3434

2.62

226.67

2.2

2.0

12.98

10.80

mg/l

14.69

1468

3267

Coronary revascularization (ANGIO or CABG)

2174

6080

2.23

226.66

2.6

2.1

11.76

11.49

mg/l

0.47

2055

5695

Infections, IBD-co-morbidities

512

687

5.49

222.89

1.8

2.3

12.85

10.68

mg/l

4.80

466

660

Chronic lower respiratory diseases

3131

8651

1.94

221.15

2.2

2.1

11.03

11.45

mg/l

1.94

2969

8108

Cardiomyopathy, other and unspecified

370

602

6.77

220.95

3.7

1.7

12.30

11.57

mg/l

0.87

351

554

Emergency coronary revascularization (for ACS)

2291

6597

2.15

218.23

2.5

2.1

11.81

11.60

mg/l

0.34

2165

6158

Immunodeficiencies

316

447

8.26

218.00

3.0

2.1

11.65

11.87

mg/l

0.15

306

411

Ischemic heart diseases

2243

6335

2.16

215.93

2.5

2.1

11.37

11.42

mg/l

0.10

2109

5939

Oedema, not elsewhere classified

924

2974

3.14

214.12

2.1

1.9

12.42

11.44

mg/l

2.54

854

2779

Asthma, hospital admissions , main diagnosis only

2250

9629

2.08

213.75

2.2

2.1

10.95

11.48

mg/l

2.63

2135

9019

Implicit Sepsis

2070

7202

2.17

211.92

2.1

13.44

11.07

mg/l

19.16

1928

6765

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

820

1089

3.86

211.04

2.2

1.9

11.32

10.76

mg/l

0.77

769

1023

Implicit Sepsis, including avohilmo

2211

7704

2.10

206.54

2.1

13.13

11.00

mg/l

17.55

2063

7245

Major coronary heart disease event

2239

6473

2.12

205.79

2.5

2.1

11.77

11.55

mg/l

0.35

2109

6055

1340

5444

2.52

204.81

2.2

2.1

11.05

11.54

mg/l

1.35

1263

5093

Undetermined asthma, excluding more controls

406

767

5.56

204.54

1.9

1.2

10.99

10.87

mg/l

0.11

375

710

Abnormal findings on examination of blood, without diagnosis

1386

5222

2.48

200.87

1.9

2.0

12.02

11.91

mg/l

0.16

1288

4909

Chronic iridocyclitis

305

459

7.63

198.21

3.2

2.1

10.60

12.02

mg/l

1.79

293

424

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2376

8118

2.02

197.84

2.1

12.68

10.85

mg/l

17.71

2224

7648

Other diseases of pleura

1275

4459

2.57

196.92

1.8

2.0

11.63

12.26

mg/l

1.36

1199

4141

Paroxysmal tachycardia

686

1629

3.64

191.82

3.3

1.9

11.17

10.11

mg/l

1.86

657

1546

Liquid cancers

939

3155

2.94

190.07

1.8

2.0

14.37

11.72

mg/l

3.50

861

2939

Hard cardiovascular diseases

2194

6412

2.07

189.10

2.5

2.1

11.55

11.27

mg/l

0.81

2064

6015

Other soft tissue disorders, not elsewhere classified

2388

6919

2.00

187.40

2.0

2.1

11.45

11.39

mg/l

0.09

2223

6536

ILD, hospital admissions 3, with pneumonia sepsis

362

676

5.81

186.80

2.0

12.17

11.97

mg/l

0.11

339

618

Undetermined asthma

406

832

5.12

186.49

1.9

1.2

10.99

10.98

mg/l

0.01

375

771

Asthma, including avohilmo

2987

9063

1.85

183.77

2.1

10.97

11.54

mg/l

3.32

2824

8491

Condition for Implicit Sepsis (Organ dysfunction codes)

2223

7835

2.01

183.64

2.1

12.96

10.95

mg/l

18.71

2074

7377

Hypertensive diseases (excluding secondary)

1322

3098

2.55

182.93

2.2

2.0

12.02

9.99

mg/l

13.53

1236

2948

Primary_lymphoid and hematopoietic malignant neoplasms

781

2580

3.18

182.73

1.8

2.0

14.39

11.80

mg/l

2.60

721

2402

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2519

8443

1.92

180.29

2.6

2.0

11.78

11.19

mg/l

2.18

2352

7979

Atrial fibrillation and flutter

862

1827

3.15

179.31

2.6

2.0

11.39

10.27

mg/l

3.59

809

1726

Bacterial Sepsis

1306

4582

2.42

177.51

2.0

14.23

11.47

mg/l

13.21

1196

4277

Obesity related asthma

1088

4339

2.60

177.20

2.5

2.1

10.81

11.57

mg/l

2.47

1026

4057

Implicit bacterial Sepsis, including avohilmo

1269

4458

2.44

174.65

1.9

2.0

14.25

11.51

mg/l

12.41

1162

4158

Other and unspecified dermatitis

1490

6860

2.23

173.63

2.2

2.1

11.58

11.32

mg/l

0.45

1406

6430

Dermatitis

1719

8219

2.10

170.27

2.2

2.1

11.58

11.37

mg/l

0.39

1619

7711

COPD/asthma/ILD related infections

2444

6435

1.94

169.46

2.1

11.90

10.98

mg/l

3.01

2277

6085

COPD/asthma related infections

2444

6435

1.94

169.46

2.1

11.90

10.98

mg/l

3.01

2277

6085

Acute renal failure

691

2221

3.25

169.16

2.2

1.8

16.94

11.25

mg/l

24.02

637

2059

Pleural effusion

528

1439

3.88

168.06

1.7

1.9

11.40

12.95

mg/l

2.14

501

1325

Implicit bacterial Sepsis

1158

4110

2.49

167.76

1.9

14.46

11.55

mg/l

12.17

1059

3829

Chorioretinal inflammation

224

293

9.25

166.59

2.6

2.2

10.53

11.53

mg/l

0.85

219

267

Other necrotizing vasculopathies (FG)

278

453

6.77

165.94

1.8

2.3

11.78

12.00

mg/l

0.11

253

415

Liquid cancers, including Hilmo

1068

3792

2.57

165.65

1.8

2.0

14.08

11.65

mg/l

3.73

981

3549

Other disorders of lacrimal gland

1113

4637

2.49

164.86

2.8

2.1

11.17

11.57

mg/l

0.95

1047

4315

Other necrotizing vasculopathies

329

636

5.69

164.19

1.8

2.1

12.09

12.31

mg/l

0.14

302

583

Disorders of other endocrine glands

1249

5387

2.35

163.72

1.9

2.1

11.44

11.51

mg/l

0.09

1129

5063

Persons encountering health services for specific procedures and health care

2676

8800

1.82

161.54

2.5

2.0

11.82

11.06

mg/l

4.15

2522

8273

Heart failure and bmi 25plus

996

2530

2.72

161.46

2.3

2.1

13.54

12.16

mg/l

3.77

922

2340

Atrial fibrillation and flutter with reimbursement

707

1378

3.35

160.84

2.7

2.0

11.66

10.42

mg/l

3.78

666

1296

Presence of cardiac and vascular implants and grafts

1172

3612

2.46

159.65

3.3

1.9

12.28

mg/l

0.00

1093

3374

Erythema nodosum

209

268

9.26

157.46

2.9

2.3

11.98

11.97

mg/l

0.01

197

255

Asthma-related pneumonia

1009

4086

2.54

157.16

2.1

1.9

11.73

12.11

mg/l

0.66

955

3791

Asthma, hospital admissions 3, pneumonia

1009

4095

2.53

156.40

2.1

1.9

11.73

12.11

mg/l

0.65

955

3800

Asthma-related pneumonia or sepsis

1009

4095

2.53

156.40

2.1

1.9

11.73

12.11

mg/l

0.65

955

3800

Certain infectious and parasitic diseases

2272

6021

1.92

154.49

2.1

12.23

10.65

mg/l

6.91

2118

5689

Disorders of lacrimal system

1262

5617

2.28

153.40

2.7

2.1

11.15

11.58

mg/l

1.06

1188

5226

Eosinophilic disease (BM)

122

21.20

152.97

1.7

1.2

12.20

11.11

mg/l

0.46

113

Aplastic and other anaemias

1223

5006

2.30

150.42

1.7

2.0

13.74

11.92

mg/l

5.83

1123

4660

Other and unspecified anaemias

1142

4669

2.36

150.42

1.7

1.9

13.60

11.95

mg/l

4.59

1051

4339

Abnormalities of heart beat

917

3512

2.60

150.40

2.4

2.0

10.95

11.56

mg/l

1.27

863

3274

Other anaemias

1149

4696

2.36

150.32

1.7

1.9

13.61

11.95

mg/l

4.68

1058

4363

Any reimbursement code in KELA

1326

2876

2.35

150.31

2.1

2.2

11.31

10.33

mg/l

2.47

1254

2731

Non-allergic asthma (mode), excluding more controls

436

1105

4.04

150.00

2.2

1.2

10.95

10.97

mg/l

0.02

420

1027

Other special examinations and investigations of persons without complaint or reported diagnosis

1490

3450

2.23

149.56

2.1

2.0

11.53

10.81

mg/l

1.95

1397

3282

Tramadol

1989

6236

1.95

148.26

2.1

2.2

12.03

11.12

mg/l

4.84

1859

5887

Implicit viral Sepsis, including avohilmo

872

3415

2.63

146.47

2.3

1.9

13.32

11.40

mg/l

5.60

810

3196

Dermatitis and eczema

2740

9434

1.75

143.21

2.1

11.63

11.34

mg/l

0.73

2576

8859

Symptoms and signs involving the skin and subcutaneous tissue

1866

9413

1.91

141.89

2.2

2.1

11.44

11.42

mg/l

0.02

1744

8840

Asthma/COPD (KELA code 203)

2312

8642

1.82

141.67

2.1

10.98

11.45

mg/l

2.17

2189

8101

Disorders of thyroid, IBD co-morbidities

446

759

4.15

141.41

2.5

2.2

11.76

10.64

mg/l

2.12

422

730

Other diseases of blood and blood-forming organs, wide

708

2569

2.88

139.95

2.0

2.1

12.49

11.63

mg/l

0.82

653

2392

Pain in limb

1996

6784

1.90

139.58

2.1

11.74

11.40

mg/l

0.72

1858

6409

Allergic asthma (mode), excluding more controls

508

1480

3.44

138.18

2.0

1.2

10.98

10.43

mg/l

1.12

487

1383

Metabolic disorders

2331

7870

1.81

136.93

2.2

12.40

10.93

mg/l

7.17

2184

7417

Other or ill-defined heart diseases

236

399

6.42

135.25

4.3

1.8

11.36

11.05

mg/l

0.24

224

371

Disorders of eyelid, lacrimal system and orbit

2161

8858

1.82

135.19

2.4

2.0

11.36

11.48

mg/l

0.28

2033

8304

Syncope and collapse

1022

3663

2.38

135.15

2.1

1.9

11.87

11.38

mg/l

1.14

940

3426

2652

7850

1.74

131.65

2.1

11.81

11.36

mg/l

1.44

2461

7392

Other joint disorders

1996

5598

1.89

130.66

2.1

11.22

11.02

mg/l

0.46

1876

5282

L04AA Selective immunosuppressants

710

2679

2.77

130.09

2.2

13.35

11.27

mg/l

3.93

666

2513

Non-allergic asthma (mode)

436

1220

3.65

130.06

2.2

1.2

10.95

11.15

mg/l

0.22

420

1133

Arthropathies

2044

5600

1.87

129.47

2.0

2.1

11.80

11.02

mg/l

1.73

1924

5284

Gout

716

2290

2.77

128.86

2.0

15.62

11.78

mg/l

6.27

657

2134

Diseases of oesophagus, stomach and duodenum

2552

8868

1.72

127.80

2.0

2.2

11.51

11.23

mg/l

0.86

2385

8360

Other diseases of pericardium

201

307

7.20

127.69

1.8

1.7

12.79

11.62

mg/l

0.89

188

285

Antihypertensive medication - note that there are other indications

1374

3407

2.14

127.17

2.3

1.9

11.49

10.12

mg/l

4.46

1301

3230

Pain, not elsewhere classified

702

2655

2.72

126.79

1.9

2.0

10.81

11.04

mg/l

0.34

660

2487

Viral Sepsis

616

2188

2.93

126.26

2.4

2.0

13.69

11.58

mg/l

4.07

575

2042

Sleep apnoea

2328

8486

1.76

126.22

2.4

2.1

11.17

11.59

mg/l

1.46

2180

7981

Implicit viral Sepsis

613

2183

2.92

125.04

2.4

2.0

13.70

11.59

mg/l

4.04

572

2037

Rheumatoid arthritis

829

3003

2.51

124.19

1.7

2.1

11.91

11.26

mg/l

1.44

765

2816

Diseases of the respiratory system

1363

3249

2.14

123.85

2.0

2.1

11.62

11.09

mg/l

0.93

1276

3055

Allergic asthma (mode)

508

1585

3.21

123.67

2.0

1.2

10.98

10.57

mg/l

0.73

487

1483

Septicaemia

1033

4279

2.25

122.16

2.1

2.0

14.04

11.51

mg/l

7.78

948

3991

Neurological diseases, wide definition

621

1015

3.14

119.58

2.1

2.2

10.76

10.47

mg/l

0.43

584

973

Idiopathic pulmonary fibrosis

283

630

4.83

119.01

1.5

1.9

11.14

13.71

mg/l

2.28

261

574

Diseases of the eye and adnexa

1793

4799

1.90

118.66

2.2

2.0

11.42

10.95

mg/l

0.78

1702

4548

Urticaria and erythema

1002

4599

2.24

118.09

2.2

11.22

11.23

mg/l

0.00

934

4322

Hypertension, essential

1854

5740

1.86

117.51

2.2

2.3

12.20

10.54

mg/l

6.60

1737

5438

Hypothyroidism (congenital or acquired)

561

995

3.23

117.43

2.3

2.1

9.98

9.88

mg/l

0.12

534

959

Explicit Sepsis, including avohilmo

1106

4776

2.15

115.92

2.1

1.9

13.91

11.36

mg/l

8.71

1017

4469

Sleep apnoea, including avohilmo

2394

8627

1.70

115.36

2.4

2.1

11.09

11.58

mg/l

1.93

2235

8124

Hypothyroidism, levothyroxine purchases

554

991

3.21

114.68

2.3

2.1

10.00

9.88

mg/l

0.15

527

955

Hypothyroidism and >3 levothyroxin purchases

554

991

3.21

114.68

2.3

2.1

10.00

9.88

mg/l

0.15

527

955

Disorders of parathyroid gland

598

2174

2.83

114.61

1.8

2.0

13.07

12.22

mg/l

1.03

528

2012

Explicit Sepsis

1082

4681

2.15

114.38

2.1

1.9

14.00

11.38

mg/l

8.92

996

4378

Polymyalgia rheumatica

406

1200

3.56

114.37

1.5

2.0

11.41

12.47

mg/l

1.41

369

1095

General examination and investigation of persons without complaint and reported diagnosis

1352

3448

2.07

114.34

2.1

2.0

12.10

10.81

mg/l

2.09

1260

3280

Chronic sinusitis

1120

5423

2.11

114.32

2.2

2.1

11.06

11.43

mg/l

0.84

1060

5098

Codeine

2143

6659

1.76

114.21

2.2

2.1

11.55

11.08

mg/l

1.24

2004

6290

Opioids

2239

6714

1.75

113.98

2.0

2.1

11.69

11.07

mg/l

1.98

2097

6341

COPD (mode)

584

1607

2.90

113.09

1.8

1.2

13.06

11.59

mg/l

2.05

536

1494

Diseases of the skin and subcutaneous tissue

2211

6422

1.75

112.92

2.1

11.82

11.14

mg/l

2.14

2083

6017

Haemorrhage from respiratory passages

801

2990

2.43

112.00

2.0

1.9

12.39

11.99

mg/l

0.47

745

2780

Sicca syndrome [Sjögren]

320

821

4.18

111.87

1.9

2.2

10.83

12.36

mg/l

1.87

300

756

Bronchitis

2554

9377

1.66

110.73

2.1

11.63

11.37

mg/l

0.73

2371

8835

Other septicaemia, including avohilmo

932

3979

2.25

110.63

2.1

2.0

14.23

11.56

mg/l

7.41

858

3706

Sulfasalazine

668

2644

2.60

110.10

1.7

1.5

11.28

11.37

mg/l

0.10

618

2457

Other septicaemia

913

3899

2.26

109.65

2.0

14.30

11.55

mg/l

7.55

840

3632

Gout, FINNGEN

716

2916

2.51

109.57

2.0

1.9

15.62

11.98

mg/l

5.71

657

2717

Episodal and paroxysmal disorders

2442

7453

1.68

108.79

2.2

2.0

11.31

11.43

mg/l

0.19

2287

6989

Hypertensive diseases

1852

5871

1.81

107.95

2.2

2.3

12.37

10.52

mg/l

7.64

1732

5561

Low back pain

1835

7025

1.79

107.86

2.0

2.2

11.46

11.37

mg/l

0.19

1706

6622

Hypertension

1849

5869

1.81

107.26

2.2

2.3

12.37

10.52

mg/l

7.64

1728

5559

Endocrine, nutritional and metabolic diseases

1733

4783

1.86

107.03

2.1

11.71

10.50

mg/l

2.82

1629

4544

Non-Hodgkin lymphoma, all, including Hilmo

407

1258

3.40

106.85

2.0

12.39

11.83

mg/l

0.60

384

1168

Covid-19 confirmed case

951

4454

2.19

106.08

2.1

2.0

12.78

11.81

mg/l

1.68

879

4170

Early onset COPD, excluding more controls

419

1323

3.26

104.88

2.1

1.2

11.96

11.31

mg/l

0.83

394

1233

Unspecified kidney failure

325

881

3.88

104.34

2.5

1.8

18.73

11.85

mg/l

12.20

297

802

Dorsalgia

2240

7144

1.68

100.81

2.0

2.2

11.54

11.39

mg/l

0.25

2095

6735

Provisional assignment of new diseases of uncertain etiology

1308

6935

1.91

100.30

2.1

2.0

12.41

11.45

mg/l

2.55

1219

6493

Pericarditis

152

223

7.46

100.23

2.0

1.8

11.93

11.32

mg/l

0.30

141

210

Codes for special purposes

1309

6943

1.91

100.22

2.1

2.0

12.41

11.44

mg/l

2.56

1219

6502

Codeine or tramadol medication

2579

8768

1.62

100.16

2.2

2.1

11.77

11.28

mg/l

1.64

2408

8255

Continuous positive airway pressure

480

1374

3.01

99.83

2.8

2.0

13.86

10.89

mg/l

10.63

440

1300

Valvular heart disease excluding rheumatic fever

1004

3427

2.13

99.22

2.1

1.9

12.86

11.36

mg/l

2.92

931

3193

Non-rheumatic valve diseases

999

3405

2.14

98.90

2.1

1.9

12.86

11.37

mg/l

2.87

927

3173

Eosinophilia

122

144

10.33

98.81

1.7

2.4

12.20

12.37

mg/l

0.06

113

136

Other disorders of skin and subcutaneous tissue

1726

8437

1.76

98.63

2.2

2.1

12.52

11.44

mg/l

4.16

1626

7890

Left bundle-branch block

241

553

4.62

97.23

2.6

1.7

11.20

11.75

mg/l

0.50

228

508

Depression medications

590

1062

2.85

97.18

1.9

2.1

10.79

9.92

mg/l

1.10

561

1024

Diseases of the musculoskeletal system and connective tissue

1116

2711

2.10

96.94

2.1

2.2

11.84

11.01

mg/l

0.87

1050

2574

Other disorders of white blood cells

233

528

4.81

96.47

1.9

2.1

12.18

11.95

mg/l

0.13

216

492

Visual disturbances and blindness

1284

6919

1.89

96.08

2.1

11.92

11.52

mg/l

0.48

1192

6470

Hyperparathyroidism

506

1856

2.80

95.54

1.8

2.0

13.29

12.48

mg/l

0.81

448

1711

Other acute lower respiratory infections

1283

6606

1.88

94.30

2.0

11.61

11.60

mg/l

0.02

1197

6198

Persons encountering health services in other circumstances, wide

2572

8376

1.60

93.80

2.1

11.13

11.59

mg/l

1.59

2413

7871

Nerve, nerve root and plexus disorders

2444

9268

1.60

93.63

2.2

2.1

11.32

11.46

mg/l

0.36

2306

8699

Acute upper respiratory infections

2354

8836

1.62

93.15

2.1

11.51

11.44

mg/l

0.12

2185

8315

Arthropathies in other diseases classified elsewhere

171

306

6.18

93.11

3.3

2.3

13.43

10.23

mg/l

3.39

155

279

Certain infectious and parasitic diseases, including avohilmo

1525

4206

1.84

92.09

2.1

12.04

10.67

mg/l

3.16

1417

3983

Asthma and allergy, excluding more controls

286

758

3.84

91.98

2.0

1.2

10.53

10.09

mg/l

0.56

273

708

Other diseases of intestines

2381

8328

1.61

91.81

2.1

11.63

11.13

mg/l

1.77

2229

7857

Diabetes mellitus

2319

8389

1.62

91.07

2.4

2.1

12.49

10.84

mg/l

7.70

2184

7912

Diabetes, varying definitions

2307

8380

1.62

90.63

2.4

2.1

12.50

10.83

mg/l

7.81

2172

7905

Hypothyroidism, strict autoimmune

1508

5569

1.80

90.41

2.2

2.1

11.15

11.44

mg/l

0.62

1410

5227

Other specified/unspecified systemic involvement of connective tissue

233

555

4.55

90.37

1.6

2.3

11.12

12.11

mg/l

0.80

219

513

Type 2 diabetes

2247

8109

1.63

90.11

2.4

2.1

12.55

10.85

mg/l

7.68

2110

7646

Visual disturbances

1192

6417

1.90

89.92

2.1

11.78

11.50

mg/l

0.28

1110

6007

Erysipelas, including avohilmo

1633

7033

1.75

89.89

2.0

2.2

12.66

11.02

mg/l

10.10

1518

6616

Glomerular diseases

505

1935

2.71

89.81

1.8

2.0

16.89

11.60

mg/l

15.87

465

1802

Rheumatoid arthritis, including avohilmo

939

4670

2.06

89.77

1.7

2.1

11.67

11.81

mg/l

0.19

870

4348

Complications of surgical and medical care, not elsewhere classified

2273

9559

1.61

89.59

2.1

12.09

11.28

mg/l

3.56

2116

9005

Neurological diseases

1824

5365

1.73

89.52

2.1

2.0

11.15

11.43

mg/l

0.41

1707

5053

Soft tissue disorders

2202

6957

1.64

89.41

2.0

2.1

11.49

11.39

mg/l

0.16

2041

6574

Parasetamol

1524

4287

1.82

89.08

2.1

11.57

10.94

mg/l

0.88

1438

4053

Osteopathies and chondropathies

1347

6880

1.82

88.46

2.3

2.1

12.00

11.58

mg/l

1.00

1243

6430

Acute myeloid leukaemia and myelodysplastic syndromes

121

159

8.55

88.46

1.5

2.1

24.81

12.49

mg/l

1.51

148

Symptoms and signs concerning food and fluid intake

293

826

3.69

88.21

1.6

1.8

12.63

11.12

mg/l

2.01

264

771

Acute sinusitis

1280

6431

1.84

87.06

2.2

11.58

11.15

mg/l

0.83

1200

6078

Persons encountering health services for examination and investigation

1294

3450

1.91

86.99

2.0

12.05

10.81

mg/l

1.95

1212

3282

Diseases of arteries, arterioles and capillaries (FINNGEN)

537

1424

2.67

86.10

2.0

13.14

10.31

mg/l

9.16

493

1342

Nutritional anaemias

1155

5939

1.89

85.71

1.9

2.0

13.01

11.72

mg/l

3.61

1060

5548

Acute bronchitis

976

4906

1.99

85.01

2.1

2.0

11.60

11.69

mg/l

0.11

906

4587

Gastro-oesophageal reflux disease

1580

7852

1.72

84.90

2.0

2.2

11.50

11.40

mg/l

0.15

1450

7399

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2447

8364

1.57

84.30

2.1

11.22

11.58

mg/l

1.01

2299

7861

Other and unspecified iron deficiency

834

4056

2.10

84.18

2.0

12.75

11.70

mg/l

2.37

780

3789

Other pleural conditions

297

876

3.56

84.05

1.5

1.9

11.15

12.92

mg/l

1.52

280

796

Acute upper respiratory infections of multiple and unspecified sites

1758

7738

1.68

84.04

2.1

11.30

11.32

mg/l

0.03

1635

7297

Iron deficiency anaemia

1014

5199

1.95

83.39

1.9

2.0

12.77

11.71

mg/l

2.96

935

4857

Asthma and allergy

286

812

3.58

83.05

2.0

1.2

10.53

10.25

mg/l

0.31

273

763

Type 2 diabetes, wide definition

1771

6738

1.68

82.45

2.3

2.1

13.23

11.04

mg/l

8.19

1639

6329

Gout, idiopatic and unspecified

614

2675

2.37

82.44

2.1

1.9

15.03

12.07

mg/l

8.73

563

2490

Migraine

1179

4988

1.87

82.19

2.3

2.1

10.82

11.08

mg/l

0.46

1128

4696

Lower back pain or/and sciatica

2420

9796

1.55

81.64

2.0

2.1

11.41

11.40

mg/l

0.03

2257

9221

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

908

2805

2.08

81.57

2.4

2.0

11.63

9.99

mg/l

7.91

856

2666

Diseases of liver

884

4458

2.03

81.41

2.2

2.1

12.04

11.66

mg/l

0.59

829

4172

Cerebrovascular diseases (FINNGEN)

660

2022

2.34

80.87

2.0

12.19

10.11

mg/l

8.17

617

1912

Intestinal infectious diseases, including avohilmo, including avohilmo

2537

9290

1.54

80.07

2.1

12.23

11.20

mg/l

4.32

2382

8737

Other and unspecified polyneuropathies, also in other diseases

507

2058

2.55

79.97

2.2

1.9

12.33

12.14

mg/l

0.15

463

1924

Spondylopathies

1746

6233

1.68

79.95

2.0

2.2

11.25

11.57

mg/l

0.88

1633

5869

Myalgia

622

2760

2.32

79.85

2.1

2.2

11.05

11.28

mg/l

0.37

583

2607

Coagulation defects, purpura and other haemorrhagic conditions

535

2236

2.48

79.14

2.0

2.1

12.54

11.62

mg/l

0.95

501

2084

Other headache syndromes

985

5181

1.93

78.87

2.1

10.92

11.28

mg/l

0.59

936

4854

Type 2 diabetes, definitions combined

2113

7810

1.59

78.54

2.4

2.1

12.41

10.89

mg/l

5.87

1981

7362

Later onset COPD, excluding more controls

372

954

3.04

78.17

1.5

1.1

13.27

12.29

mg/l

0.65

338

871

Hypothyroidism, drug reimbursement

313

651

3.45

77.98

2.1

2.0

11.45

9.89

mg/l

3.41

299

627

Erysipelas

1210

5865

1.81

76.99

2.1

12.92

11.28

mg/l

7.57

1123

5497

Intestinal infectious diseases

2104

10089

1.57

76.66

2.1

12.48

11.18

mg/l

4.91

1966

9487

Chronic rhinitis, nasopharyngitis and pharyngitis

809

4038

2.05

76.52

2.1

11.15

11.35

mg/l

0.34

768

3793

Type 2 diabetes, strict (exclude DM1)

2115

7871

1.58

76.38

2.4

2.1

12.40

10.89

mg/l

5.86

1983

7421

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

178

393

4.88

75.92

2.2

2.1

12.23

mg/l

0.00

161

365

Primary hyperparathyroidism

345

1189

3.05

75.59

1.5

2.1

11.79

11.99

mg/l

0.16

300

1102

Purpura and other haemorrhagic conditions

388

1427

2.83

74.95

2.1

2.0

12.02

11.69

mg/l

0.28

363

1323

Other nutritional deficiencies

1563

8713

1.66

74.50

2.2

2.1

11.79

11.18

mg/l

1.68

1464

8215

Osteoporosis

647

2743

2.23

74.37

2.5

1.9

11.99

12.38

mg/l

0.45

578

2509

Dialysis, with operation codes

353

1242

2.97

74.19

1.8

1.9

21.53

10.92

mg/l

29.93

315

1152

Type 2 diabetes, definitions combined, including avohilmo

2105

7830

1.57

74.02

2.4

2.1

12.41

10.86

mg/l

6.09

1976

7383

Gout, unspecified

506

2133

2.45

73.40

2.1

1.9

15.26

11.94

mg/l

9.57

465

1993

Fibromyalgia

297

954

3.26

73.36

1.8

2.3

10.39

10.87

mg/l

0.58

277

917

Polyneuropathies and other disorders of the peripheral nervous system

549

2415

2.35

72.24

2.1

1.9

12.18

12.16

mg/l

0.01

505

2257

Transplanted organ and tissue status

293

943

3.26

72.17

1.9

17.64

11.14

mg/l

6.95

269

884

Complications of medical and surgical care

1655

9277

1.63

72.00

2.2

2.1

12.53

11.34

mg/l

4.84

1539

8709

Other dorsopathies, not elsewhere classified

2133

7160

1.56

71.73

2.0

2.2

11.70

11.38

mg/l

0.61

1991

6751

Scleritis and episcleritis

227

627

3.87

71.59

1.7

2.2

10.68

12.29

mg/l

1.57

219

587

Pain (limb, back, neck, head abdominally)

1461

4303

1.72

70.94

2.0

2.1

11.78

11.39

mg/l

0.44

1363

4057

Other disorders involving the immune mechanism, not elsewhere classified

135

250

5.93

70.85

2.2

1.2

14.59

11.13

mg/l

2.96

124

231

Polyarthrosis

490

1844

2.46

70.70

1.8

2.1

11.32

11.56

mg/l

0.26

449

1714

Dental caries

634

2801

2.19

70.48

2.0

2.1

14.29

11.26

mg/l

6.75

587

2623

Bronchiectasis

239

690

3.65

70.22

2.3

2.0

11.71

12.60

mg/l

0.75

224

630

Lung cancer and mesothelioma

341

1003

2.95

69.95

1.7

1.2

11.79

11.89

mg/l

0.08

319

932

Caries of dentine

575

2513

2.27

69.68

2.0

2.1

14.25

11.24

mg/l

5.91

532

2359

Diarrhoea and gastroenteritis of presumed infectious origin

1577

8751

1.63

69.49

2.2

2.1

12.79

11.15

mg/l

5.09

1470

8225

Gastrointestinal diseases

1207

3384

1.81

69.43

2.0

2.2

11.58

10.47

mg/l

2.61

1128

3210

Viral pneumonia

343

1231

2.89

69.25

2.1

2.0

13.58

11.20

mg/l

1.01

318

1147

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2211

9406

1.52

69.01

2.1

12.18

11.18

mg/l

3.49

2069

8849

Follow-up examination after treatment for conditions other than malignant neoplasms

861

2946

1.98

68.84

2.3

2.1

12.50

10.81

mg/l

2.29

797

2800

Abnormal findings on diagnostic imaging of other body structures

366

1371

2.77

68.10

2.5

1.8

11.17

11.75

mg/l

0.59

351

1269

Exclusions for E4_PCOS_BROAD

464

1949

2.46

67.83

2.1

9.67

11.41

mg/l

4.32

432

1829

Giant cell arteritis

161

360

4.85

67.81

1.9

2.0

11.73

12.75

mg/l

0.85

148

327

Non-invasive ventilation

521

1956

2.35

67.78

2.0

13.60

10.49

mg/l

13.31

483

1859

Other diseases of upper respiratory tract

2278

7891

1.52

67.38

2.1

11.38

11.60

mg/l

0.51

2138

7391

Symptoms and signs involving the digestive system and abdomen

2098

6858

1.55

67.20

2.1

11.59

11.41

mg/l

0.36

1961

6471

Seropositive rheumatoid arthritis

542

2427

2.27

67.06

1.7

2.2

11.82

11.41

mg/l

0.53

500

2258

Acute tubulo-interstitial nephritis

1306

6577

1.70

67.02

1.9

2.0

13.51

10.61

mg/l

9.99

1196

6161

Symptoms and signs involving the nervous and musculoskeletal systems

1298

7794

1.69

66.94

1.9

2.1

10.02

11.79

mg/l

13.16

1220

7280

Disorders of conjunctiva

1866

9380

1.56

66.86

2.2

2.1

11.09

11.33

mg/l

0.67

1745

8816

Factors influencing health status and contact with health services

582

1263

2.35

66.49

2.2

1.9

12.34

10.90

mg/l

1.03

539

1212

Sleep disorders (combined)

2328

8149

1.51

66.41

2.1

11.18

11.57

mg/l

1.32

2151

7670

Gout, strict definition

445

1862

2.47

65.74

2.0

1.8

15.31

12.13

mg/l

7.00

404

1740

Dorsopathies

2143

7172

1.53

64.83

2.0

2.2

11.52

11.37

mg/l

0.22

2000

6763

Abnormal results of function studies

253

795

3.33

64.81

2.0

1.8

11.38

11.46

mg/l

0.05

239

743

Vocal cord dysfunction

306

928

2.98

64.25

2.2

2.3

11.30

10.42

mg/l

1.26

283

882

Myeloid leukaemia

125

237

5.85

64.19

1.5

2.1

23.47

12.48

mg/l

1.41

106

218

Obesity and other hyperalimentation

1455

8537

1.63

63.76

2.2

2.1

11.88

11.11

mg/l

2.31

1363

8047

Hernia of abdominal wall, postoperative

386

1519

2.58

63.55

2.3

2.0

13.82

10.63

mg/l

2.02

365

1434

Disorders of lipoprotein metabolism and other lipidaemias

1768

6906

1.58

63.35

2.1

2.2

12.70

11.08

mg/l

6.16

1662

6485

Non-follicular lymphoma

272

907

3.15

63.16

2.0

1.9

12.20

12.27

mg/l

0.04

261

833

Secondary hypertension

204

559

3.74

62.76

1.8

16.64

10.56

mg/l

8.52

179

531

Secondary and unspecified malignant neoplasm of lymph nodes

248

786

3.31

62.76

1.9

2.1

12.24

11.75

mg/l

0.38

236

727

Bacterial pneumoniae

855

4050

1.89

62.63

2.0

12.76

11.48

mg/l

4.06

801

3795

Obesity

1444

8512

1.62

62.47

2.2

2.1

11.89

11.12

mg/l

2.32

1354

8023

Hypertensive heart and/or renal disease

563

1888

2.23

62.31

1.7

1.9

16.01

11.36

mg/l

5.94

513

1748

Other symptoms and signs involving the nervous and musculoskeletal systems

971

5500

1.80

62.16

2.0

2.1

9.20

11.66

mg/l

18.56

922

5141

Disorders of optic nerve and visual pathways

286

993

3.02

61.82

2.1

10.98

11.41

mg/l

0.40

270

931

Bleeding

1762

8026

1.56

61.78

2.0

2.1

12.54

11.48

mg/l

3.82

1636

7534

Obesity due to excess calories

1114

6573

1.72

61.67

2.2

11.74

11.08

mg/l

1.38

1043

6191

Abdominal and pelvic pain

2061

6858

1.52

61.50

2.1

11.48

11.41

mg/l

0.13

1937

6471

Acute myeloid leukaemia, helper endpoint

106

9.03

61.31

1.5

2.2

28.91

12.01

mg/l

1.36

Acute myeloid leukaemia

106

9.03

61.31

1.5

2.2

28.91

12.01

mg/l

1.36

Acute myeloid leukaemia, including Hilmo

106

9.03

61.31

1.5

2.2

28.91

12.01

mg/l

1.36

Disturbances of skin sensation

682

3474

2.01

61.17

2.2

2.1

10.95

11.25

mg/l

0.50

638

3266

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1147

6578

1.71

61.04

2.0

2.1

10.99

11.53

mg/l

1.16

1075

6184

Disorders of choroid and retina

1731

7863

1.56

61.03

2.2

2.1

12.73

11.54

mg/l

3.18

1617

7358

Nephropathy related operations

332

1255

2.76

61.00

1.7

2.0

21.57

11.42

mg/l

25.89

297

1165

Glomerular disorders in diseases classified elsewhere

324

1210

2.79

60.96

1.9

2.1

17.94

11.50

mg/l

15.21

295

1119

All influenza

580

2789

2.13

60.79

2.3

2.1

13.26

11.41

mg/l

2.75

543

2627

L04AD Calcineurin inhibitors

318

1180

2.82

60.69

2.4

2.1

16.76

11.06

mg/l

7.13

299

1114

Complications of procedures, not elsewhere classified

1755

9267

1.54

60.47

2.1

11.92

11.32

mg/l

2.26

1637

8720

Arthrosis

1422

4781

1.65

60.23

2.0

2.2

11.77

11.19

mg/l

1.40

1344

4502

Other/unspecified dorsalgia

839

4537

1.86

59.91

2.0

2.2

12.09

11.52

mg/l

0.46

779

4270

Symptoms and signs involving cognition, perception, emotional state and behaviour

2086

9460

1.49

58.84

2.1

11.70

11.34

mg/l

1.06

1945

8914

Seronegative rheumatoid arthritis

287

1023

2.91

58.79

1.6

2.2

12.12

11.32

mg/l

0.79

264

956

Shoulder lesions

1584

6049

1.59

58.65

2.0

2.2

11.36

11.58

mg/l

0.49

1490

5705

Disorders of the thyroid gland

1982

8632

1.51

58.64

2.2

2.1

11.23

11.46

mg/l

0.58

1865

8093

Ischaemic heart disease, wide definition

1617

6407

1.57

57.78

1.9

2.2

11.81

11.58

mg/l

0.47

1510

5999

Other disorders of skin and subcutaneous tissue, not elsewhere classified

368

1499

2.54

57.77

2.2

2.0

13.58

11.68

mg/l

2.98

342

1385

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

118

233

5.52

57.68

2.0

1.2

15.10

11.08

mg/l

3.22

108

214

Bacterial pneumonia (organism specified)

939

4851

1.78

57.56

2.0

12.70

11.91

mg/l

1.78

877

4523

Bacterial pneumonia, not elsewhere classified

796

3799

1.87

57.03

2.0

12.84

11.52

mg/l

4.58

745

3561

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1975

7881

1.50

56.98

2.2

2.1

12.87

10.88

mg/l

8.27

1843

7430

Respiratory insufficiency

160

401

4.10

56.89

2.1

1.1

10.80

12.20

mg/l

1.04

149

369

Noninfective enteritis and colitis

1031

6085

1.72

56.68

1.9

2.1

12.15

11.30

mg/l

1.73

960

5722

Other intervertebral disc disorders

1722

6728

1.54

56.29

2.1

2.2

11.45

mg/l

0.01

1614

6342

Presence of other functional implants

1199

4970

1.67

56.25

2.0

1.9

11.06

11.93

mg/l

2.38

1109

4653

Other respiratory disorders and diseases

463

2107

2.26

56.12

1.9

11.72

12.31

mg/l

0.58

437

1941

Other diseases of the respiratory system

463

2107

2.26

56.12

1.9

11.72

12.31

mg/l

0.58

437

1941

Gonarthrosis [arthrosis of knee](FG)

1453

5265

1.61

56.06

2.1

2.2

11.73

11.26

mg/l

0.99

1373

4952

Implicit fungal Sepsis, including avohilmo

214

665

3.38

56.03

2.0

2.1

12.98

11.69

mg/l

0.99

198

616

SLE (Finngen)

126

270

5.02

55.81

1.7

2.4

12.26

11.55

mg/l

0.44

117

253

Care involving dialysis

230

751

3.21

55.45

1.7

2.0

24.21

11.43

mg/l

23.84

204

696

STROKE

1115

4472

1.70

55.42

2.0

2.1

12.29

11.02

mg/l

2.05

1039

4197

Other disorders of adrenal gland

159

411

4.13

55.23

2.4

2.1

9.52

11.71

mg/l

2.47

150

386

Neoplasms

1562

5242

1.58

55.22

2.0

2.1

11.49

10.74

mg/l

1.98

1472

4973

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1942

10311

1.48

54.90

2.3

2.1

11.40

11.38

mg/l

0.03

1821

9693

Coronary atherosclerosis

1258

4880

1.65

54.63

1.9

2.0

12.39

11.80

mg/l

0.71

1171

4554

Disorders of lens

1411

5533

1.60

54.60

2.2

2.1

12.73

11.41

mg/l

2.55

1316

5206

Persons encountering health services in other circumstances

904

5148

1.77

54.59

2.0

2.1

10.79

11.56

mg/l

1.82

853

4826

Other disorders of fluid, electrolyte and acid-base balance

677

3358

1.94

54.32

1.8

1.9

12.60

11.70

mg/l

1.63

612

3109

Urticaria

698

3728

1.91

54.31

2.2

11.06

11.20

mg/l

0.17

647

3516

Budesonide

315

1226

2.64

54.20

2.2

1.6

11.76

11.48

mg/l

0.22

291

1140

Other CVD (FINNGEN)

253

649

3.06

53.62

2.2

1.8

13.78

10.70

mg/l

4.93

233

611

Diverticular disease of intestine

1508

6056

1.57

53.51

2.1

2.2

12.38

11.44

mg/l

3.71

1409

5678

Hypothyroidism, other/unspecified

1822

8084

1.50

52.79

2.2

2.1

11.12

11.45

mg/l

0.87

1708

7574

Conjunctivitis

1639

8790

1.52

52.43

2.2

2.1

11.11

11.27

mg/l

0.35

1535

8271

ILD-related respiratory insufficiency

125

281

4.82

52.40

2.0

2.2

11.98

12.49

mg/l

0.23

116

255

Subjective visual disturbances

609

3153

1.98

52.24

2.4

2.1

11.46

11.61

mg/l

0.19

567

2953

Other (seronegative) rheumatoid arthritis, wide

457

2135

2.20

52.10

1.6

2.0

11.87

11.88

mg/l

0.00

420

1983

Adrenocortical insufficiency

139

341

4.40

52.04

2.5

2.2

9.74

11.77

mg/l

1.96

131

318

Biological medication for rheuma

461

2167

2.19

51.75

1.7

2.2

10.40

11.12

mg/l

1.23

438

2061

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1305

8194

1.58

51.68

2.1

12.62

11.43

mg/l

3.67

1215

7679

Hypertensive Heart Disease

493

1763

2.17

51.61

1.7

1.9

15.42

11.38

mg/l

3.82

446

1633

Conjunctivitis (acute, non atopic), including avohilmo

2115

8890

1.45

51.42

2.2

2.1

11.42

11.46

mg/l

0.07

1998

8356

Amiodarone users

265

976

2.83

51.36

3.9

1.8

12.48

12.66

mg/l

0.10

251

897

Ulcer of lower limb, not elsewhere classified

346

1446

2.47

51.36

2.1

1.9

15.57

12.42

mg/l

4.32

316

1327

Viral infections characterized by skin and mucous membrane lesions

934

5524

1.72

51.17

2.4

2.1

11.64

11.45

mg/l

0.26

879

5175

COPD

872

4078

1.76

50.91

1.8

1.9

12.46

12.36

mg/l

0.09

811

3783

Other noninfective gastroenteritis and colitis

562

2854

2.01

50.79

2.0

2.1

12.67

11.53

mg/l

1.27

526

2674

Secondary uncertain malignant neoplasm

314

1263

2.56

50.62

1.9

2.0

12.15

11.79

mg/l

0.30

295

1173

Other disorders of optic [2nd] nerve and visual pathways

194

607

3.37

50.38

2.4

2.2

11.78

11.76

mg/l

0.01

182

564

Migraine with aura

556

2822

2.01

50.27

2.3

2.1

10.99

11.09

mg/l

0.13

526

2662

Hypothyreosis and Thyroxine purchase for inclusion criteria

1893

8514

1.47

50.26

2.2

2.1

11.08

11.47

mg/l

1.21

1777

7978

Other bacterial intestinal infections, including avohilmo

538

2712

2.03

49.81

1.8

2.0

12.77

11.41

mg/l

2.40

496

2529

Other diseases of liver

465

2231

2.15

49.54

2.3

2.1

11.31

11.46

mg/l

0.14

439

2092

5-aminosalicylic acid

415

1899

2.23

49.49

1.9

1.5

11.95

11.25

mg/l

0.89

380

1781

Other bacterial intestinal infections

426

1976

2.21

49.36

1.7

2.0

13.11

11.52

mg/l

2.24

387

1835

Osteoporosis with pathological fracture (FG)

185

568

3.40

49.30

2.8

2.2

11.16

12.19

mg/l

0.74

158

519

Vasomotor and allergic rhinitis

816

4589

1.77

49.26

2.0

2.1

10.59

11.14

mg/l

1.54

761

4314

Suggestive for eosinophilic asthma

247

897

2.87

49.15

2.0

11.21

11.94

mg/l

0.84

233

837

Nausea and vomiting

578

2919

1.97

49.07

2.1

1.9

12.35

11.82

mg/l

0.68

533

2730

Chronic gastritis

571

2956

1.97

48.88

1.9

2.0

13.28

12.11

mg/l

2.11

524

2739

Abnormal findings on diagnostic imaging of central nervous system

155

428

3.82

48.87

1.9

11.20

11.57

mg/l

0.10

147

396

Dizziness and giddiness

1581

8254

1.51

48.54

2.1

11.73

11.49

mg/l

0.47

1467

7752

Irritable bowel syndrome

635

3417

1.90

48.34

2.0

2.1

10.98

11.18

mg/l

0.29

602

3200

Infections of the skin and subcutaneous tissue

1267

8057

1.57

48.23

2.2

2.1

12.68

11.25

mg/l

4.98

1191

7580

Rheumatism, unspecified

333

1410

2.44

48.11

2.1

2.2

10.46

11.37

mg/l

1.34

306

1324

Other arthrosis

1031

4196

1.67

47.65

2.0

2.2

11.69

11.31

mg/l

0.85

972

3950

Keratitis

779

4478

1.77

47.56

2.2

2.1

11.43

11.63

mg/l

0.26

735

4184

Papilloedema, unspecified

100

203

5.40

47.53

2.5

2.3

11.17

11.83

mg/l

0.34

191

Other disorders of eye and adnexa

366

1626

2.32

47.34

2.6

2.1

11.01

11.41

mg/l

0.45

339

1522

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

360

1588

2.33

47.28

1.8

2.1

12.00

11.56

mg/l

0.45

341

1479

Insulin medication

1247

6659

1.57

47.14

2.2

2.1

14.00

11.20

mg/l

7.52

1170

6247

Other inflammation of eyelid

359

1595

2.32

46.42

2.0

2.1

11.15

11.78

mg/l

0.80

339

1492

Myelodysplastic syndrome, including Hilmo

102

214

5.11

46.34

1.6

2.1

16.04

12.46

mg/l

1.22

197

Thrombocytopenia, unspecified

203

686

3.10

46.19

2.0

11.49

12.04

mg/l

0.36

191

631

Non-Hodgkin lymphoma, all

130

331

4.15

45.98

1.5

2.0

11.98

12.50

mg/l

0.25

116

305

Bacterial intestinal infections, IBD co-morbidities

422

2006

2.16

45.96

1.7

2.0

13.28

11.89

mg/l

1.58

382

1867

Oxycodone

810

4033

1.74

45.92

1.7

2.0

12.38

11.61

mg/l

1.46

738

3769

Sciatica+with lumbago

1091

6086

1.61

45.73

2.1

2.2

11.14

11.50

mg/l

0.91

1024

5742

Diseases of salivary glands

742

4261

1.78

45.60

2.1

11.41

11.43

mg/l

0.03

693

3991

Temporal arteritis

125

313

4.28

45.52

1.8

2.0

11.22

12.57

mg/l

1.15

114

283

Dysphagia

542

2825

1.96

45.52

2.0

1.9

11.20

11.99

mg/l

1.31

501

2649

Conjunctivitis (acute, non atopic)

633

3453

1.86

45.49

2.1

11.50

11.35

mg/l

0.17

599

3249

Disorders of synovium and tendon

1104

5918

1.60

45.33

2.0

2.2

11.44

11.42

mg/l

0.01

1040

5592

Care involving use of rehabilitation procedures

1292

7625

1.54

45.22

2.1

2.0

11.78

11.22

mg/l

1.51

1220

7159

Gonarthrosis

1209

4334

1.59

45.19

2.1

2.2

11.76

11.27

mg/l

0.91

1146

4070

Chronic laryngitis and laryngotracheitis

345

1528

2.33

44.95

2.2

2.0

11.30

11.70

mg/l

0.49

317

1425

Ocular pain

244

928

2.74

44.49

2.8

2.2

10.57

11.58

mg/l

1.06

227

873

Other cataract

908

4069

1.68

44.21

2.2

2.1

12.62

11.61

mg/l

1.09

849

3806

Diabetes medication

2149

8996

1.41

44.21

2.3

2.1

12.75

10.94

mg/l

7.99

2010

8482

Insulin, combination of fast acting with intermediate-acting or long-acting

1247

7408

1.54

44.17

2.2

2.0

14.00

11.45

mg/l

6.36

1170

6935

Diabetes, insulin treatment (Kela reimbursement)

2075

8831

1.41

43.42

2.2

2.1

12.88

11.03

mg/l

7.78

1934

8312

Diseases of the digestive system

922

5631

1.65

43.41

1.9

2.0

12.56

11.90

mg/l

0.83

859

5255

Pure hypercholesterolaemia

1508

6474

1.49

43.22

2.0

2.2

13.19

11.18

mg/l

7.17

1416

6069

Systemic lupus erythematosus

126

331

4.08

42.97

1.7

2.2

12.26

11.75

mg/l

0.29

117

311

Localized swelling, mass and lump of skin and subcutaneous tissue

691

3957

1.78

42.87

2.3

2.1

11.84

11.63

mg/l

0.20

658

3698

Symptoms and signs involving the urinary system

1546

7993

1.47

42.60

1.9

2.1

12.14

11.58

mg/l

0.88

1435

7492

Senile cataract

1231

4860

1.56

42.43

2.2

2.1

12.93

11.58

mg/l

2.20

1148

4557

Mycoses

631

3536

1.82

42.26

2.1

2.0

12.02

11.68

mg/l

0.41

593

3306

Spondyloarthritis

397

1904

2.13

42.21

1.9

2.1

11.70

11.72

mg/l

0.01

369

1784

Other viral diseases, including avohilmo

818

4873

1.69

42.17

2.0

2.2

11.53

11.01

mg/l

1.17

777

4594

Enterocolitis due to Clostridium difficile

253

1005

2.60

42.02

1.6

1.9

14.23

12.44

mg/l

1.19

228

923

Other antidepressants

2064

7531

1.41

42.01

1.9

2.1

11.37

11.47

mg/l

0.18

1936

7089

Pulmonary heart disease, diseases of pulmonary circulation

657

3730

1.79

41.96

2.0

12.23

12.14

mg/l

0.08

604

3465

Tumor necrosis factor alpha inhibitors

402

1947

2.12

41.86

1.7

2.2

10.26

11.20

mg/l

1.64

382

1848

Spondylosis

1105

5548

1.58

41.79

1.8

2.2

10.65

11.70

mg/l

4.23

1031

5210

Spondylopathies (FG)

311

1361

2.35

41.62

1.9

2.3

10.93

10.80

mg/l

0.11

294

1282

Other chronic obstructive pulmonary disease

803

3917

1.70

41.55

1.8

1.9

12.55

12.45

mg/l

0.08

745

3627

Depression

1979

9493

1.41

41.53

2.0

2.2

11.46

11.25

mg/l

0.46

1858

8936

Mood disorders, excluding more controls

1953

8184

1.41

41.53

2.0

2.2

11.56

11.34

mg/l

0.50

1827

7716

Episcleritis

165

528

3.29

41.42

1.6

2.2

10.55

12.47

mg/l

1.61

158

497

Abnormal weight loss

240

938

2.66

41.39

1.5

2.0

12.28

12.02

mg/l

0.16

216

864

Glomerulonephritis

248

986

2.61

41.28

1.7

2.0

15.32

11.57

mg/l

5.62

229

912

Candidiasis, including avohilmo

669

3847

1.77

40.96

2.2

2.1

11.77

11.34

mg/l

0.70

621

3606

Polyarthritis, unspecified

117

301

4.13

40.95

1.9

2.3

11.85

10.88

mg/l

0.62

106

276

Migraine without aura

436

2189

2.03

40.84

2.5

2.1

10.92

10.93

mg/l

0.01

420

2078

Mood [affective] disorders

2094

9730

1.39

40.82

2.0

2.1

11.52

11.32

mg/l

0.46

1961

9151

Nonalcoholic fatty liver disease

275

1155

2.47

40.73

2.4

2.1

11.55

11.56

mg/l

0.01

261

1084

Diseases of arteries, arterioles and capillaries

1304

6399

1.51

40.46

1.9

2.0

13.89

11.69

mg/l

5.79

1200

5968

Giant cell arteritis with polymyalgia rheumatica

125

341

3.92

40.44

1.8

2.0

11.22

12.69

mg/l

1.34

114

311

Mood disorders

2096

9740

1.39

40.40

2.0

2.1

11.52

11.32

mg/l

0.46

1963

9160

Anxiety disorders, excluding more controls

1730

7784

1.43

40.13

2.2

11.20

11.25

mg/l

0.07

1623

7338

Hypopituitarism

204

747

2.85

40.09

2.1

2.2

8.57

11.28

mg/l

5.67

194

711

Chronic ulcer of skin, not elsewhere classified

180

616

3.05

40.04

1.8

2.0

13.55

12.20

mg/l

0.84

165

560

Major coronary heart disease event excluding revascularizations

1106

4706

1.57

39.95

1.9

2.0

12.85

11.95

mg/l

1.13

1026

4378

Internal derangement of knee

712

4152

1.72

39.69

2.0

2.2

11.14

11.17

mg/l

0.04

661

3909

Inflammatory diseases of the central nervous system

229

894

2.67

39.68

2.1

11.60

11.46

mg/l

0.08

211

835

Other inflammation of eyelid, including avohilmo

942

5968

1.60

39.45

2.2

2.1

10.93

11.18

mg/l

0.51

890

5606

Disorders of gallbladder, biliary tract and pancreas

2001

9013

1.39

39.39

2.2

2.1

12.07

11.30

mg/l

1.94

1859

8500

Diffuse large B-cell lymphoma, including Hilmo

141

425

3.50

39.02

2.0

2.1

11.42

12.12

mg/l

0.44

133

390

Diffuse large B-cell lymphoma

141

425

3.50

39.02

2.0

2.1

11.42

12.12

mg/l

0.44

133

390

Diffuse large B-cell lymphoma, helper endpoint

141

425

3.50

39.02

2.0

2.1

11.42

12.12

mg/l

0.44

133

390

Neurotic, stress-related and somatoform disorders

1843

9113

1.41

38.83

2.1

2.2

11.18

11.25

mg/l

0.13

1727

8593

Reactive arthropathies, FINNGEN

177

612

3.00

38.62

1.8

2.3

11.32

10.93

mg/l

0.24

171

571

Weight loss

248

1018

2.52

38.56

1.5

2.0

12.38

11.95

mg/l

0.30

224

938

Cervicalgia

458

2392

1.95

38.40

2.0

2.2

11.50

11.76

mg/l

0.30

437

2244

Disorders of skin appendages

1051

6837

1.55

38.21

2.1

11.02

11.19

mg/l

0.28

997

6421

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1169

7807

1.51

38.01

2.1

12.52

11.51

mg/l

3.52

1087

7308

Fungal Sepsis

130

379

3.62

37.93

1.9

2.2

13.26

11.46

mg/l

1.18

123

351

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

736

4438

1.69

37.90

2.3

2.1

10.78

11.46

mg/l

1.74

692

4153

Intracranial trauma

1070

4687

1.56

37.75

2.2

2.1

11.24

11.37

mg/l

0.16

997

4430

Other skin changes

434

2243

1.98

37.61

2.5

2.0

11.99

11.94

mg/l

0.04

396

2085

Anxiety disorders

1851

9172

1.40

37.58

2.1

2.2

11.17

11.26

mg/l

0.15

1734

8646

Agranulocytosis

271

1173

2.39

37.46

1.8

2.0

11.06

11.57

mg/l

0.19

251

1090

Diplopia

310

1420

2.25

37.35

1.8

2.0

12.81

11.78

mg/l

0.31

293

1321

Asthma and opportunity respiratory infection

138

423

3.45

37.26

2.4

2.0

11.28

13.04

mg/l

1.26

128

384

Lumbar disc prolapse

1287

6477

1.49

37.10

2.2

11.16

11.46

mg/l

0.78

1212

6114

Other retinal disorders

1247

6415

1.49

36.75

2.1

2.0

13.09

11.77

mg/l

2.42

1162

5977

Rotator cuff syndrome

1211

5600

1.50

36.56

1.9

2.2

11.30

11.65

mg/l

0.81

1147

5273

Collagenous colitis

234

960

2.53

36.51

2.2

2.0

11.97

11.81

mg/l

0.10

214

895

Hyperlipidaemia, other/unspecified

753

4133

1.66

36.16

2.1

1.9

12.29

11.61

mg/l

1.18

710

3835

Chronic apical periodontitis

2240

9356

1.35

36.12

2.0

2.1

11.59

11.37

mg/l

0.52

2090

8814

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1092

5676

1.53

36.00

2.2

2.0

14.33

11.65

mg/l

6.40

1014

5301

Other functional intestinal disorders

898

5207

1.59

35.88

1.9

2.1

11.43

11.47

mg/l

0.05

841

4876

Exposure to unspecified factor

2050

10315

1.36

35.76

2.0

2.1

11.84

11.30

mg/l

1.84

1908

9712

Hypothyroidism, strict autoimmune, 3 medication purchases required

1646

7894

1.41

35.76

2.2

2.1

11.15

11.42

mg/l

0.64

1541

7384

Benign neoplasms

1932

7659

1.38

35.70

2.0

2.1

11.75

11.19

mg/l

1.50

1816

7231

Endocarditis

223

4.38

35.67

2.2

1.7

13.64

11.98

mg/l

0.68

210

Other viral diseases

604

3497

1.75

35.64

2.0

2.1

11.78

11.00

mg/l

1.57

573

3305

Other and unspecified urticaria

435

2296

1.94

35.44

2.2

2.1

11.17

11.30

mg/l

0.11

398

2165

Cardiodefibrillation

674

4039

1.69

35.13

2.2

1.9

12.52

12.25

mg/l

0.22

618

3766

Angina pectoris

1004

4332

1.56

35.04

1.9

2.0

11.99

11.94

mg/l

0.06

950

4034

Fibrosis and cirrhosis of liver

199

774

2.67

34.81

2.2

2.0

13.12

12.21

mg/l

0.59

190

716

Meniscus derangement

1002

4331

1.55

34.70

2.0

2.2

11.24

11.28

mg/l

0.06

937

4072

Granulomatous disorders of skin and subcutaneous tissue

256

4.16

34.66

2.0

2.3

11.27

11.75

mg/l

0.22

239

Implicit fungal Sepsis

121

358

3.57

34.57

1.9

2.2

13.25

11.48

mg/l

1.08

114

333

Adalimumab

260

1147

2.34

34.45

1.7

2.2

10.03

11.39

mg/l

1.97

246

1088

Depression or dysthymia

1355

5098

1.47

34.45

2.0

2.2

11.16

11.57

mg/l

1.03

1266

4798

Other medical care

925

5023

1.56

34.40

1.6

1.9

12.26

11.70

mg/l

1.01

856

4674

Allergic rhinitis

648

3825

1.70

34.37

1.9

2.2

10.63

11.00

mg/l

0.73

604

3619

Pulmonary embolism

585

3408

1.75

34.25

2.0

12.18

12.12

mg/l

0.05

537

3168

Pneumonia due to other infectious organisms, not elsewhere classified

103

276

3.95

34.12

1.9

2.2

11.78

11.57

mg/l

0.08

256

SLE, strict definition

119

353

3.60

34.05

1.7

2.2

12.14

11.53

mg/l

0.35

110

331

SLE, ICD10

119

353

3.60

34.05

1.7

2.2

12.14

11.53

mg/l

0.35

110

331

Concussion

926

4644

1.56

33.95

2.2

2.1

10.82

11.38

mg/l

0.97

862

4389

Pulmonary heart disease

585

3425

1.74

33.65

2.0

12.18

12.15

mg/l

0.03

537

3184

Coxibs

505

1426

1.88

33.61

1.8

2.1

11.03

12.87

mg/l

3.52

466

1339

Noninfectious colitis NAS

308

1467

2.15

33.59

1.9

2.1

12.64

11.38

mg/l

1.83

291

1374

Extracorporeal dialysis

165

595

2.90

33.58

1.7

2.1

25.52

11.62

mg/l

18.98

144

551

Insulin, intermediate and long-acting

1067

6937

1.50

33.51

2.1

2.0

14.05

11.47

mg/l

5.92

1000

6494

Hypertrophic cardiomyopathy

128

401

3.38

33.45

3.2

2.1

10.54

11.99

mg/l

1.12

117

369

Diseases of the ear and mastoid process

2277

8605

1.34

33.11

2.1

11.42

11.27

mg/l

0.20

2121

8125

Functional dyspepsia

561

3264

1.75

33.06

2.0

2.2

11.08

11.50

mg/l

0.62

526

3067

Seropositive rheumatoid arthritis, wide

542

3128

1.77

32.95

1.7

2.1

11.82

11.97

mg/l

0.15

500

2899

Zoster [herpes zoster], including avohilmo

1026

6644

1.51

32.94

2.3

2.0

11.72

11.74

mg/l

0.02

958

6185

Other (not insulin) diabetes medications

1951

8505

1.36

32.44

2.3

2.1

12.62

10.98

mg/l

6.80

1820

8016

Other disorders of urethra and urinary system

1371

6720

1.43

32.35

2.1

11.78

11.42

mg/l

0.82

1276

6324

Insulin, fast-acting

721

4503

1.62

32.19

2.4

2.0

13.46

11.31

mg/l

6.83

675

4224

DVT of lower extremities and pulmonary embolism

803

5130

1.58

31.96

2.1

2.0

12.34

11.92

mg/l

0.62

738

4765

Failure and rejection of transplanted organs and tissues

122

5.73

31.79

1.8

2.8

17.09

13.01

mg/l

0.44

116

Drug-induced cataract

241

4.14

31.78

3.9

2.4

13.14

12.29

mg/l

0.38

223

Urinary track infection

1156

3916

1.49

31.77

2.2

11.60

10.74

mg/l

2.82

1087

3696

Wegener granulomatosis

145

5.27

31.74

1.8

2.4

10.20

12.06

mg/l

1.02

136

Idiopathic gout

213

896

2.45

31.49

2.1

1.8

14.21

11.58

mg/l

3.50

198

832

Other disorders of conjunctiva

316

1559

2.08

31.46

2.2

2.0

11.26

12.03

mg/l

0.88

293

1448

Venous thromboembolism

1037

6783

1.49

31.33

2.1

2.0

12.28

11.88

mg/l

0.72

964

6306

Cardiac arrest

133

365

3.18

31.24

2.6

1.7

11.56

10.73

mg/l

0.51

126

346

Hypokalaemia

267

1238

2.21

31.24

2.0

13.20

11.51

mg/l

1.94

243

1144

Rash and other nonspecific skin eruption

220

944

2.40

31.08

2.2

2.0

11.13

11.93

mg/l

0.68

208

875

Recurrent or chronic depression

850

3807

1.57

31.06

2.2

2.4

11.10

11.21

mg/l

0.16

804

3603

Protozoal diseases

101

286

3.78

31.06

2.2

2.4

12.03

12.20

mg/l

0.06

267

Other infectious diseases, including avohilmo

211

891

2.44

30.92

2.4

2.0

12.81

11.95

mg/l

0.60

199

824

Other gastritis (incl. Duodenitis)

449

2505

1.83

30.68

2.1

2.0

12.56

12.02

mg/l

0.63

423

2346

Reactive arthropathies

201

833

2.49

30.68

1.8

2.2

11.39

10.63

mg/l

0.79

194

782

Spinal stenosis

948

4643

1.52

30.62

2.0

2.1

12.12

12.03

mg/l

0.12

878

4336

Pain in thoracic spine

336

1710

2.01

30.56

1.7

2.2

11.25

11.67

mg/l

0.45

316

1611

Obesity, other/unspecified

706

4450

1.61

30.47

2.3

2.2

12.00

11.00

mg/l

2.86

655

4195

Diaphragmatic hernia

712

4499

1.61

30.42

2.1

2.0

12.46

11.81

mg/l

1.40

660

4170

Malignant neoplasm, including Hilmo

1729

7422

1.37

30.27

2.1

2.2

12.18

11.04

mg/l

2.54

1613

7013

Migraine with aura and triptan purchases

356

1856

1.96

30.19

2.4

2.2

10.85

10.66

mg/l

0.23

340

1765

Other diseases of intestine

338

1732

2.00

30.18

2.0

1.9

12.86

11.79

mg/l

1.44

322

1615

Genitourinary diseases

1064

3588

1.50

30.05

2.2

2.1

12.14

10.55

mg/l

2.82

996

3418

Use of hypnotics and sedatives

2106

9141

1.33

29.99

2.1

2.2

11.83

11.33

mg/l

1.46

1959

8630

Benign neoplasm of colon, rectum, anus and anal canal

1224

7287

1.43

29.98

2.2

2.0

12.86

11.79

mg/l

4.69

1142

6787

Benign neoplasm: Colon

1040

6695

1.47

29.83

2.2

2.0

13.08

11.87

mg/l

5.05

969

6225

Other specified/unspecified necrotizing vasculopathies

118

5.62

29.75

2.2

2.3

12.19

13.15

mg/l

0.37

111

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

520

3055

1.73

29.72

1.6

2.1

11.88

11.96

mg/l

0.07

478

2832

Myocardial infarction

845

3849

1.55

29.60

1.9

2.0

13.25

11.98

mg/l

1.35

787

3581

Cytomegalovirus infection, IBD co-morbidity

226

4.11

29.56

1.5

2.4

12.76

11.67

mg/l

0.45

211

Other/unspecified seropositive rheumatoid arthritis

525

3097

1.73

29.55

1.6

2.1

11.88

11.98

mg/l

0.10

483

2869

Methotrexate

252

1167

2.20

29.49

1.7

1.5

11.88

11.76

mg/l

0.07

235

1078

Malignant neoplasm, wide definition

1727

7440

1.36

29.46

2.1

2.2

12.19

11.06

mg/l

2.47

1611

7028

Other and unspecified types of non-Hodgkin lymphoma, hilmo

117

376

3.27

29.32

1.7

2.0

12.70

12.31

mg/l

0.19

108

349

Childhood asthma (age<16), excluding more controls

190

594

2.53

29.27

2.1

1.2

10.85

9.89

mg/l

1.21

184

558

Other viral diseases, not elsewhere classified, including avohilmo

546

3240

1.70

29.24

2.1

2.2

11.51

10.94

mg/l

1.04

521

3059

Other reaction to severe stress, and adjustment disorders

745

4800

1.57

29.09

2.3

2.2

11.05

10.95

mg/l

0.14

696

4538

Vasculitis limited to skin, not elsewhere classified

242

3.93

29.05

1.7

2.3

11.10

12.42

mg/l

0.71

226

310

1564

2.03

28.96

2.4

2.1

11.98

11.29

mg/l

0.69

290

1474

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1090

7271

1.45

28.88

2.2

11.03

11.12

mg/l

0.15

1018

6836

Ulcerative colitis, NAS

310

1568

2.02

28.80

1.9

2.1

11.61

11.14

mg/l

0.48

279

1479

Symptoms and signs involving speech and voice

669

4222

1.61

28.80

1.9

2.1

11.35

11.78

mg/l

0.70

614

3952

Soft tissue disorders related to use, overuse and pressure

550

3308

1.69

28.72

2.2

11.42

11.57

mg/l

0.19

510

3109

Unspecified acute lower respiratory infection

336

1749

1.96

28.68

2.1

11.92

11.55

mg/l

0.33

319

1637

Streptococcal septicaemia, including avohilmo

192

804

2.45

28.63

2.2

2.0

12.61

11.25

mg/l

1.13

173

749

Protozoal diseases, including avohilmo

102

307

3.54

28.58

2.1

2.3

12.04

12.13

mg/l

0.03

284

Other disorders of kidney and ureter

282

1384

2.09

28.54

2.2

2.0

15.86

11.69

mg/l

7.63

256

1282

Other anxiety disorders

944

5438

1.49

28.54

2.0

2.2

11.09

10.95

mg/l

0.23

878

5144

Streptococcal septicaemia

188

781

2.47

28.54

2.3

2.0

12.81

11.27

mg/l

1.34

170

728

Other complications of surgical and medical care, not elsewhere classified

223

1000

2.29

28.45

2.2

2.0

11.47

mg/l

0.00

210

932

Emphysema

160

617

2.67

28.44

1.6

2.0

11.25

13.40

mg/l

1.29

151

564

Thyroiditis, ILD-related definition

256

1214

2.16

28.37

2.3

2.2

11.28

11.45

mg/l

0.12

241

1137

Other and unspecified rosacea

223

1004

2.29

28.26

2.2

2.1

11.20

11.66

mg/l

0.34

212

932

Mycoses, including avohilmo

1820

10467

1.33

28.25

2.1

11.65

11.33

mg/l

0.92

1690

9856

Coxarthrosis [arthrosis of hip](FG)

928

4286

1.50

28.21

2.0

2.2

11.92

11.54

mg/l

0.81

870

4019

Pleural plaque

180

739

2.50

28.03

1.6

1.7

11.80

13.84

mg/l

1.45

164

674

Insulin, fast-acting or short human

721

4654

1.57

28.01

2.4

2.0

13.46

11.54

mg/l

5.26

675

4367

Somatoform disorder

352

1877

1.92

27.94

2.2

2.1

10.27

11.45

mg/l

2.27

331

1768

Drug-induced osteoporosis with pathological fracture

157

4.75

27.88

3.3

2.1

9.87

12.64

mg/l

1.79

148

Disorders of orbit

122

414

3.09

27.82

1.9

2.3

11.75

12.44

mg/l

0.38

117

387

Myelodysplastic syndrome

6.28

27.65

1.3

1.9

14.65

12.68

mg/l

0.36

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1883

9029

1.33

27.57

2.3

2.1

11.92

11.38

mg/l

1.89

1764

8505

Explicit bacterial Sepsis

221

999

2.27

27.57

2.2

2.0

13.08

11.77

mg/l

0.96

203

929

Cholelithiasis, broad definition with cholecystitis

1677

8339

1.35

27.54

2.2

2.1

12.05

11.36

mg/l

1.35

1554

7846

Oxicams

416

1287

1.86

27.39

1.9

2.1

11.86

12.99

mg/l

1.35

387

1212

Glucagon-like peptide-1 (GLP-1) analogues

662

4221

1.59

27.36

2.5

2.2

12.08

11.15

mg/l

2.12

635

3973

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

662

4221

1.59

27.36

2.5

2.2

12.08

11.15

mg/l

2.12

635

3973

Other enthesopathies

591

3669

1.63

27.19

2.1

2.2

11.12

11.31

mg/l

0.23

558

3468

FESS (DNB20)

288

1451

2.04

27.17

2.4

2.1

10.43

11.53

mg/l

1.23

272

1363

Convulsions, not elsewhere classified

375

2026

1.85

27.16

1.9

2.0

10.44

10.85

mg/l

0.53

350

1913

Zoster [herpes zoster]

380

2095

1.85

27.13

2.5

1.9

12.14

12.18

mg/l

0.03

357

1933

Cervical disc disorders

693

4475

1.57

26.98

2.0

2.2

11.49

11.72

mg/l

0.38

659

4198

Carpal tunnel syndrome

1196

7412

1.41

26.97

2.1

11.08

11.53

mg/l

1.25

1141

6935

Explicit bacterial Sepsis, including avohilmo

225

1034

2.23

26.96

2.2

2.0

12.91

11.79

mg/l

0.79

206

961

Special screening examination for infectious and parasitic diseases

440

1818

1.79

26.91

2.2

11.63

10.24

mg/l

5.50

400

1752

Enthesopathies of lower limb, excluding foot

477

2814

1.72

26.87

2.3

2.2

11.29

11.48

mg/l

0.20

449

2650

Other and unspecified disorders of white blood cells

114

381

3.14

26.76

2.2

2.3

11.98

12.08

mg/l

0.04

106

354

Hypoparathyroidism

104

330

3.32

26.68

2.5

2.2

12.28

12.51

mg/l

0.08

308

Asthma mixed form (mode), excluding more controls

249

3.63

26.65

1.9

1.1

10.21

10.63

mg/l

0.17

232

Allergic conjunctivitis

1134

7768

1.42

26.63

2.2

11.01

11.09

mg/l

0.12

1056

7302

Malignant neoplasm

1664

7288

1.35

26.62

2.0

2.2

12.18

11.06

mg/l

2.32

1553

6882

Ethmoidectomy

294

1503

2.01

26.60

2.4

2.1

10.39

11.57

mg/l

1.40

278

1413

Cytomegaloviral disease, including avohilmo

249

3.75

26.44

1.5

2.4

12.73

11.79

mg/l

0.38

234

Malignant neoplasm

1662

7292

1.35

26.29

2.0

2.2

12.19

11.07

mg/l

2.32

1551

6886

Cytomegaloviral disease

246

3.75

26.17

1.5

2.4

12.76

11.83

mg/l

0.37

231

Other and unspecified vasculitis limited to skin

213

3.96

26.13

1.7

2.2

11.37

11.99

mg/l

0.25

199

Pollen allergy

381

2094

1.83

26.12

1.8

2.1

10.80

10.83

mg/l

0.03

350

1995

Other CVD

367

2026

1.84

26.02

2.0

1.8

13.26

12.52

mg/l

0.67

337

1866

Cholelithiasis

1605

8208

1.34

26.01

2.2

2.1

11.97

11.36

mg/l

1.06

1485

7718

Chronic tubulo-interstitial nephritis

309

3.35

25.99

2.5

2.2

18.37

10.94

mg/l

5.84

285

Chronic diseases of tonsils and adenoids

1465

6816

1.37

25.95

2.3

2.2

10.77

11.29

mg/l

1.90

1388

6415

Deforming dorsopathies

539

3310

1.65

25.93

2.2

2.1

11.57

11.50

mg/l

0.07

504

3111

Childhood asthma (age<16)

190

630

2.39

25.88

2.1

1.2

10.85

9.97

mg/l

1.08

184

594

conjunctival haemorrhage

177

751

2.44

25.81

2.0

11.61

12.41

mg/l

0.61

164

685

Suppurative and necrotic conditions of lower respiratory tract

137

515

2.76

25.79

1.9

2.1

12.67

11.74

mg/l

0.48

132

474

Cerebral cysts

145

561

2.68

25.76

1.7

2.2

11.61

11.23

mg/l

0.24

139

525

Glaucoma secondary to other eye disorders

110

368

3.12

25.72

2.8

2.1

11.81

12.26

mg/l

0.20

110

339

Psoriatic and enteropathic arthropathies

241

1165

2.12

25.41

1.5

2.3

10.51

11.04

mg/l

0.49

231

1096

Other infectious diseases

170

713

2.46

25.40

2.5

2.0

13.02

12.11

mg/l

0.54

159

656

Other and unspecified disorders of skin and subcutaneous tissue

152

606

2.60

25.40

2.7

2.2

13.67

11.94

mg/l

1.48

141

557

Other diseases of urinary system

1867

8012

1.32

25.38

2.0

2.1

11.88

11.38

mg/l

1.56

1736

7564

Coxarthrosis

854

3711

1.50

25.35

2.0

2.1

11.91

11.49

mg/l

0.87

800

3480

Encephalitis

300

3.39

25.34

1.9

2.3

11.74

11.63

mg/l

0.05

281

Inflammatory bowel disease

633

4065

1.58

25.34

1.8

2.2

11.74

11.40

mg/l

0.47

588

3830

Cystitis

1583

7043

1.35

25.33

2.1

11.76

11.39

mg/l

0.92

1486

6632

Acetic acid derivatives and related substances

473

1409

1.75

25.31

1.9

2.1

11.74

12.89

mg/l

0.99

437

1323

Benzodiazepine use

1957

10209

1.30

25.30

2.0

2.1

11.53

11.39

mg/l

0.27

1807

9626

Optic neuritis

122

439

2.91

25.11

1.7

2.2

9.83

11.27

mg/l

1.67

116

415

Neovascular glaucoma

110

374

3.07

25.03

2.8

2.2

11.81

12.09

mg/l

0.12

110

344

Systemic lupus erythematosus, unspecified

313

3.33

25.02

1.6

2.2

11.74

11.56

mg/l

0.08

292

Biguanides

1855

8590

1.31

24.97

2.2

2.1

12.44

11.11

mg/l

4.36

1719

8094

Other symptoms and signs involving the circulatory and respiratory systems

137

522

2.70

24.96

2.1

2.0

12.42

11.72

mg/l

0.40

127

485

COPD, hospital admissions

805

4574

1.50

24.89

1.8

1.9

12.45

12.32

mg/l

0.11

747

4256

Autoimmune hepatitis, wide definition

112

386

3.02

24.80

2.2

2.1

11.88

12.18

mg/l

0.12

106

353

All anxiety disorders

1245

7038

1.38

24.78

2.0

2.2

11.21

10.98

mg/l

0.39

1169

6640

Candidiasis

309

1647

1.92

24.67

2.1

11.76

11.59

mg/l

0.13

289

1538

Dermatitis due to substances taken internally

134

511

2.72

24.52

2.4

2.2

12.81

11.52

mg/l

0.61

125

470

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

202

927

2.24

24.45

2.1

2.0

12.03

11.59

mg/l

0.30

190

869

Herpesviral [herpes simplex] infections

259

1307

2.03

24.35

2.2

2.0

10.70

11.53

mg/l

0.91

241

1218

Visual impairment including blindness (binocular or monocular)

148

594

2.57

24.30

2.3

2.0

12.92

12.09

mg/l

0.47

133

544

COPD related to multimorbidity

694

3857

1.54

24.28

1.8

1.9

12.74

12.41

mg/l

0.28

641

3584

Anxiety (asthma-related co-morbidities)

1221

6760

1.38

24.27

2.0

2.3

11.23

10.92

mg/l

0.60

1146

6388

Other encephalitis

278

3.43

24.23

2.0

2.3

11.72

11.54

mg/l

0.07

261

Heart failure and hypertrophic cardiomyopathy

166

4.29

24.16

4.0

2.2

11.06

13.12

mg/l

0.92

150

Multiple myeloma, including Hilmo

106

360

3.06

24.12

1.3

2.0

15.34

12.50

mg/l

1.68

330

COPD, early/later onset

810

4621

1.49

24.10

1.8

1.9

12.53

12.31

mg/l

0.21

751

4301

Non-selective monoamine reuptake inhibitors

708

4513

1.52

24.07

2.0

2.2

12.20

11.58

mg/l

0.79

662

4205

Preparatory care for dialysis

118

427

2.90

24.05

1.8

2.2

24.40

11.59

mg/l

13.58

104

396

Other and unspecified visual disturbances

234

1144

2.10

24.04

2.0

10.99

11.80

mg/l

0.81

218

1065

Other/unspecified cytomegaloviral diseases

199

3.96

23.91

1.5

2.4

12.45

11.79

mg/l

0.23

189

Volume depletion

184

819

2.30

23.88

2.2

1.9

13.53

11.92

mg/l

1.15

163

757

Disorders resulting from impaired renal tubular function

106

364

3.07

23.82

2.2

2.3

22.18

11.79

mg/l

9.98

336

Paracetamol or NSAID medication

262

635

2.10

23.81

2.2

2.1

11.91

11.58

mg/l

0.23

241

601

Abnormal serum enzyme levels

550

3350

1.61

23.62

1.9

11.55

12.12

mg/l

0.85

513

3155

Hernia

1792

9183

1.31

23.58

2.2

2.1

12.11

11.31

mg/l

2.00

1687

8620

Hyperkalaemia

130

500

2.68

23.35

1.9

15.49

11.84

mg/l

3.14

116

461

Rosacea

282

1487

1.94

23.33

2.2

2.1

10.93

11.52

mg/l

0.60

266

1385

Other/unspecified reactive arthropathies

164

706

2.41

23.26

1.8

2.1

11.24

11.83

mg/l

0.41

159

662

Constipation

1697

8823

1.31

23.25

1.9

2.1

11.67

11.54

mg/l

0.25

1571

8292

Other peripheral vascular diseases

182

818

2.29

23.22

1.8

2.0

11.60

mg/l

0.00

174

756

Voice disturbances

529

3329

1.61

23.22

2.0

2.1

11.33

11.58

mg/l

0.32

486

3110

Cutaneous abscess, furuncle and carbuncle

521

3268

1.62

23.15

2.2

2.1

13.14

11.25

mg/l

4.27

488

3073

Other viral diseases, not elsewhere classified

360

2043

1.79

23.11

2.2

2.1

11.92

11.26

mg/l

0.81

344

1923

Other pulmonary heart/vessel disease

110

391

2.93

23.09

2.0

2.2

11.41

12.44

mg/l

0.57

104

363

Adverse effects, not elsewhere classified

401

2356

1.73

23.06

1.9

2.1

11.25

11.28

mg/l

0.03

385

2216

Viral pneumonia (unknown virus, not influenza)

160

687

2.40

22.77

2.4

2.2

11.21

11.39

mg/l

0.10

152

643

Pain and other conditions associated with female genital organs and menstrual cycle

402

1968

1.73

22.64

2.2

2.1

10.03

11.07

mg/l

2.64

377

1860

Asthma mixed form (mode)

277

3.26

22.62

1.9

1.2

10.21

11.15

mg/l

0.45

260

Nasal polyp

375

2175

1.75

22.61

2.0

11.12

12.05

mg/l

1.66

357

2042

Secondary right heart disease

102

353

3.01

22.51

1.9

2.2

11.56

12.47

mg/l

0.44

327

Other and unspecified effects of external causes

537

3415

1.59

22.50

1.9

2.1

11.19

11.15

mg/l

0.04

516

3215

Ulcerative colitis

484

3007

1.63

22.41

1.9

2.1

11.88

11.15

mg/l

1.21

449

2835

Exposure to other specified factors

1559

10258

1.31

22.35

2.0

2.1

11.66

11.27

mg/l

1.25

1460

9665

Valvular operations

225

1111

2.06

22.35

2.0

1.7

12.80

11.75

mg/l

0.88

206

1030

Exclusions for E4_PCOS_CONSORTIUM

1357

6323

1.35

22.34

2.0

2.2

10.74

11.04

mg/l

0.54

1255

5964

Pruritus

238

1202

2.02

22.33

2.2

2.1

13.19

11.30

mg/l

2.37

226

1116

Selective serotonin reuptake inhibitors

1866

7538

1.29

22.22

2.0

2.1

11.58

11.47

mg/l

0.14

1766

7096

Crystal arthropathies, rheuma endpoint

145

4.32

22.16

1.9

2.2

13.27

12.22

mg/l

0.34

128

COPD, hospital admission 2, with asthma infections

561

3098

1.58

22.09

1.9

12.67

12.52

mg/l

0.10

511

2877

Temporomandibular joint disorders, including avohilmo

877

5983

1.43

22.09

1.9

2.2

10.35

10.97

mg/l

2.03

823

5630

Triptan medication for migraine, single purchase ok

1480

7607

1.33

22.08

2.4

2.2

10.90

11.09

mg/l

0.27

1409

7156

Migraine, single triptan purchase ok & required. ICD-code if available is included

1480

7607

1.33

22.08

2.4

2.2

10.90

11.09

mg/l

0.27

1409

7156

Other neurological diseases

1331

7740

1.34

22.02

2.0

2.1

11.94

11.74

mg/l

0.19

1250

7212

Unknown and unspecified causes of morbidity

130

514

2.59

22.00

2.0

1.9

8.43

11.32

mg/l

4.03

123

480

Other crystal arthropathies

146

4.29

21.97

1.9

2.3

13.27

11.71

mg/l

0.58

128

Other chronic obstructive pulmonary disease, including avohilmo

965

5659

1.41

21.94

1.8

2.0

12.56

12.08

mg/l

0.67

899

5268

Other metabolic disorders

281

1514

1.89

21.76

2.0

2.1

11.52

11.15

mg/l

0.31

268

1419

Tuberculosis, IBD comorbidity

137

559

2.52

21.75

1.8

1.9

11.79

13.44

mg/l

0.82

118

507

Trochanteric bursitis

292

1593

1.87

21.70

2.0

2.2

11.25

11.52

mg/l

0.27

268

1493

Other diseases of anus and rectum

558

3594

1.57

21.70

2.0

11.10

11.87

mg/l

1.35

509

3350

Hypotension

305

1686

1.84

21.64

2.2

1.8

13.69

12.67

mg/l

0.85

276

1544

Other disorders of eyelid

783

5114

1.46

21.61

1.9

12.06

12.07

mg/l

0.02

728

4726

Corneal ulcer

364

2121

1.75

21.61

2.4

2.1

10.94

11.47

mg/l

0.63

342

1987

Nephrotic syndrome

277

3.26

21.60

1.6

2.2

17.99

11.89

mg/l

4.76

255

Disorders of vitreous body and globe

979

6672

1.40

21.56

2.2

2.1

11.91

11.81

mg/l

0.13

918

6220

Lichen simplex chronicus and prurigo

144

605

2.46

21.55

1.8

2.1

12.12

11.44

mg/l

0.36

135

558

Respiratory disorders in diseases classified elsewhere

141

4.42

21.46

1.9

2.3

10.88

12.60

mg/l

0.60

131

Other keratitis

236

1206

2.00

21.45

1.8

2.1

11.80

11.78

mg/l

0.01

225

1124

Other/unspecified synovitis and tenosynovitis

235

1199

2.00

21.43

2.2

11.52

11.34

mg/l

0.10

220

1142

Other diseases of lip and oral mucosa

823

5776

1.44

21.35

2.0

2.1

11.33

11.38

mg/l

0.07

763

5410

All influenza (not pneumonia)

269

1437

1.90

21.31

2.4

2.1

12.58

11.10

mg/l

1.77

251

1357

Bell's palsy

243

1259

1.97

21.23

2.7

2.1

10.91

11.90

mg/l

0.86

225

1170

Diseases of pulp and periapical tissues, including avohilmo

1935

7861

1.28

21.15

1.9

2.1

11.44

11.45

mg/l

0.02

1806

7397

Other disorders of ear

1739

8767

1.29

20.92

2.1

11.77

11.42

mg/l

0.49

1612

8249

Raynaud syndrome

201

982

2.10

20.81

1.7

2.2

11.12

11.68

mg/l

0.50

193

920

Atypical facial pain

123

492

2.59

20.52

2.0

2.2

9.84

12.43

mg/l

2.31

116

455

Cellulitis

434

2687

1.64

20.45

2.5

2.0

13.23

11.49

mg/l

3.15

406

2519

Dental caries, including avohilmo

1321

5070

1.34

20.41

2.0

11.59

mg/l

0.00

1234

4752

Missing teeth due to accident, extraction or parodontitis

1164

7758

1.35

20.40

2.0

2.1

12.30

11.68

mg/l

1.74

1068

7253

Degeneration of macula and posterior pole

820

4445

1.44

20.33

2.1

1.9

13.07

12.31

mg/l

0.63

767

4097

Fall on same level

2181

9314

1.25

20.33

2.0

2.2

11.77

11.17

mg/l

2.28

2035

8815

Cholecystectomy

1319

8511

1.33

20.23

2.2

2.1

12.12

11.45

mg/l

0.91

1229

7967

Other and unspecified drugs and medicaments

187

900

2.13

20.16

2.1

12.27

11.80

mg/l

0.31

175

836

Caries of dentine, including avohilmo

1430

5554

1.32

20.13

2.0

11.67

11.56

mg/l

0.14

1337

5205

Any event in cancer register

1735

7930

1.29

20.04

2.0

2.2

11.97

11.08

mg/l

1.78

1623

7489

Cardiomyopathy, Hypertrophic obstructive

117

4.52

20.00

4.1

1.8

10.89

11.33

mg/l

0.12

110

Other abnormal findings of blood chemistry

119

475

2.60

19.98

1.9

2.2

13.25

11.36

mg/l

1.44

113

442

Presence of other devices

407

2455

1.65

19.83

1.9

1.8

12.27

12.42

mg/l

0.08

380

2283

Other disorders of patella

315

1806

1.77

19.83

2.2

2.3

10.98

10.73

mg/l

0.27

302

1711

Migraine without aura and triptan purchases

332

1934

1.75

19.78

2.8

2.2

10.79

10.57

mg/l

0.28

319

1840

Any mental disorder

2070

8273

1.26

19.77

2.0

2.2

11.44

11.36

mg/l

0.17

1932

7799

Hypo-osmolality and hyponatraemia

309

1749

1.78

19.75

1.6

1.9

11.27

11.81

mg/l

0.52

275

1617

Early onset COPD

419

2598

1.64

19.68

2.1

2.0

11.96

12.04

mg/l

0.06

394

2428

Gastroduodenal ulcer

439

2741

1.62

19.65

1.7

1.9

13.45

12.23

mg/l

1.64

405

2557

Other diseases of hard tissues of teeth

1002

3750

1.39

19.65

2.0

2.1

11.72

11.52

mg/l

0.30

924

3505

Other inflammatory liver diseases

152

682

2.30

19.62

2.1

2.0

12.34

11.75

mg/l

0.37

142

633

Disorders of vitreous body

947

6564

1.39

19.59

2.2

2.1

11.92

11.81

mg/l

0.13

888

6123

GI-bleeding

560

3707

1.53

19.59

1.8

1.9

12.93

12.16

mg/l

0.70

520

3454

Viral hepatitis, IBD co-morbidity

346

2.84

19.52

1.5

2.4

13.36

10.34

mg/l

2.25

335

Papulosquamous disorders

755

5308

1.44

19.47

2.0

2.1

11.21

11.59

mg/l

0.66

710

4968

Tuberculosis, wide

138

595

2.38

19.44

1.8

1.9

11.82

13.59

mg/l

0.95

119

540

Calcific aortic valvular stenosis

474

2914

1.58

19.41

1.8

14.40

12.60

mg/l

2.81

438

2675

Calcific aortic valvular stenosis, operated

474

2914

1.58

19.41

1.8

14.40

12.60

mg/l

2.81

438

2675

Tuberculosis, wide, including avohilmo

139

602

2.37

19.39

1.8

2.0

11.82

13.58

mg/l

0.95

119

546

Gonarthrosis,primary

1649

7775

1.29

19.35

2.0

2.1

11.80

11.65

mg/l

0.23

1553

7266

Iron deficiency anaemia secondary to blood loss (chronic)

293

1660

1.79

19.26

1.8

2.0

12.73

12.08

mg/l

0.48

262

1533

Postprocedural endocrine and metabolic disorders, not elsewhere classified

256

1394

1.87

19.24

2.0

2.1

11.42

11.08

mg/l

0.27

245

1306

Other diseases of the digestive system

560

3723

1.52

19.23

1.9

12.92

12.14

mg/l

0.72

518

3472

Calcific aortic valvular stenosis, diagnosis (helper)

473

2913

1.58

19.22

1.8

14.41

12.60

mg/l

2.82

437

2674

Operations 2 for CAVS

473

2913

1.58

19.22

1.8

14.41

12.60

mg/l

2.82

437

2674

Other symptoms and signs involving the digestive system and abdomen

320

1860

1.75

19.21

2.1

11.57

11.65

mg/l

0.06

286

1739

Atopic dermatitis

1101

6532

1.35

19.19

2.0

2.2

11.46

10.92

mg/l

1.10

1030

6162

Other and unspecified coagulation defects

125

521

2.49

19.15

1.8

2.2

12.34

11.46

mg/l

0.54

118

490

Calcific aortic valvular stenosis, including rheumatic fever

474

2922

1.58

19.09

1.8

14.42

12.58

mg/l

2.89

438

2682

Disorder of lipoprotein metabolism, unspecified

235

1250

1.92

18.98

1.9

13.95

11.79

mg/l

2.59

218

1161

Other diseases of arteries and capillaries

180

875

2.11

18.88

2.3

1.9

17.72

11.46

mg/l

1.68

164

806

Gingivitis and periodontal diseases

1855

7600

1.27

18.79

2.0

2.1

11.88

11.28

mg/l

1.83

1733

7143

Disorders of ocular muscles, binocular movement, accommodation and refraction

910

6582

1.38

18.77

2.2

2.1

10.97

11.24

mg/l

0.49

848

6190

Injuries to the abdomen, lower back, lumbar spine and pelvis

740

5144

1.43

18.66

1.8

2.0

12.30

11.71

mg/l

1.12

688

4806

Atopic dermatitis, strict definition with reimbursement

543

3467

1.52

18.56

1.9

2.1

11.20

10.80

mg/l

0.35

513

3274

Hypogonadotropic hypogonadism

343

2.85

18.44

1.9

2.4

8.03

10.95

mg/l

2.82

329

Artrosis, including avohilmo

1533

6529

1.29

18.43

2.0

2.2

11.55

11.32

mg/l

0.38

1435

6170

Gastric ulcer

304

1763

1.75

18.40

1.8

2.0

13.54

12.33

mg/l

1.20

280

1636

Other and unspecified tonsillitis

603

3398

1.49

18.29

2.1

2.2

10.81

10.75

mg/l

0.07

574

3241

Viral pneumonia (known virus, not influenza)

247

3.18

18.18

1.8

2.1

21.59

12.77

mg/l

0.75

226

Sequelae with surgical and medical care as external cause

383

2372

1.64

18.12

1.9

2.0

11.37

11.87

mg/l

0.54

359

2207

Hypertensive Renal Disease

273

3.03

18.11

1.6

2.0

25.66

11.21

mg/l

1.88

249

Recurrent aphthous stomatitis , including avohilmo

285

1633

1.78

18.10

2.1

11.54

11.59

mg/l

0.03

267

1519

Acute generalized exanthematous pustulosis

109

439

2.58

18.02

2.7

2.2

13.47

11.69

mg/l

0.75

101

407

Seropositive rheumatoid arthritis, strict definition

295

1710

1.76

18.01

1.5

2.0

12.05

11.86

mg/l

0.13

271

1587

Sequelae of external causes of morbidity and mortality

480

3136

1.55

18.00

2.0

11.59

11.79

mg/l

0.20

448

2921

Metatarsalgia

197

1009

1.99

17.89

2.3

10.80

11.29

mg/l

0.43

185

961

Cervicobrachial syndrome

418

2651

1.60

17.87

2.3

2.2

10.90

11.50

mg/l

1.06

399

2488

Multiple myeloma and malignant plasma cell neoplasms

110

447

2.55

17.84

1.3

2.1

15.29

12.55

mg/l

1.63

103

407

Myocardial infarction, strict

721

3581

1.44

17.80

1.9

2.0

13.62

11.98

mg/l

1.62

672

3332

Diabetic nephropathy, excluding more controls

315

1508

1.74

17.75

2.0

2.1

16.78

11.90

mg/l

9.14

290

1413

Cardiac murmurs and other cardiac sounds

155

719

2.17

17.71

2.2

1.9

10.86

11.33

mg/l

0.27

147

671

Other enthesopathy of foot (+metatarsalgia)

210

1103

1.94

17.70

2.3

10.88

11.28

mg/l

0.34

196

1050

Other coagulation defects

161

771

2.14

17.66

1.8

2.2

12.15

11.45

mg/l

0.47

152

727

Glaucoma

992

6272

1.35

17.64

2.2

2.0

11.41

12.14

mg/l

1.87

923

5826

Deviated nasal septum

585

3992

1.48

17.61

2.0

2.1

11.16

11.70

mg/l

0.62

554

3761

Ovarian cyst

608

2354

1.49

17.47

2.0

2.1

11.07

11.45

mg/l

0.55

571

2215

Other diseases of stomach and duodenum

137

619

2.28

17.40

2.4

2.0

12.16

12.26

mg/l

0.05

131

569

Excessive, frequent and irregular menstruation

659

2415

1.47

17.39

2.0

2.1

11.49

11.42

mg/l

0.05

610

2271

Ankylosing spondylitis

179

898

2.04

17.28

1.9

2.1

10.92

11.76

mg/l

0.65

168

855

Dental operations

1064

4079

1.35

17.21

1.9

2.1

11.79

11.71

mg/l

0.08

994

3818

Pyogenic arthritis

128

565

2.32

17.14

2.0

2.1

12.55

11.01

mg/l

1.29

123

521

Thyrotoxicosis, other and/or unspecified

373

2329

1.62

17.08

2.5

2.1

11.42

11.37

mg/l

0.04

350

2179

Disease of hard tissues of teeth, NOS

961

3700

1.37

17.05

2.1

11.41

11.38

mg/l

0.05

899

3460

Coeliac disease

235

1296

1.85

17.03

2.1

10.96

11.32

mg/l

0.31

223

1216

Inflammatory diseases of female pelvic organs

1139

5926

1.32

16.99

2.1

2.2

10.88

11.06

mg/l

0.34

1059

5555

Fitting and adjustment of other devices

607

3690

1.46

16.98

2.1

1.9

11.02

12.08

mg/l

1.35

570

3414

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

340

2.75

16.98

2.7

2.3

12.97

12.81

mg/l

0.05

311

Diseases of the myoneural junction and muscle

232

1277

1.85

16.92

1.9

2.0

12.53

12.26

mg/l

0.13

217

1185

Demyelinating diseases of the central nervous system

185

947

2.00

16.92

1.5

2.2

9.59

11.43

mg/l

2.74

178

893

Hyperhidrosis

236

3.11

16.86

2.5

2.1

10.24

10.82

mg/l

0.28

222

Statin medication

1256

5429

1.31

16.84

2.2

12.60

10.53

mg/l

4.42

1174

5132

Other disorders of bone

372

2332

1.62

16.78

1.9

2.1

11.11

11.17

mg/l

0.05

353

2195

Diseases of oral cavity, salivary glands and jaws

987

3763

1.36

16.77

1.9

2.1

11.73

11.52

mg/l

0.24

920

3516

Dialysis

354

2.70

16.73

1.6

2.3

22.32

10.57

mg/l

9.46

329

Radiculopathy

287

1686

1.73

16.67

2.0

10.96

12.17

mg/l

1.52

271

1576

Stomatitis and related lesions

382

2415

1.61

16.64

1.9

2.1

11.80

11.41

mg/l

0.41

359

2263

Kidney transplant status

119

518

2.37

16.60

1.6

2.2

23.88

10.84

mg/l

15.35

107

484

Mature T/NK-cell lymphomas, hilmo

122

4.14

16.58

1.4

2.3

13.17

12.62

mg/l

0.13

113

Unspecified haematuria

734

4281

1.41

16.56

1.8

2.0

12.69

11.93

mg/l

1.43

685

4008

Herpesviral [herpes simplex] infections, including avohilmo

488

3265

1.51

16.40

2.3

2.1

10.87

11.17

mg/l

0.43

459

3071

COPD, hospital admissions 3, with asthma pneumonia sepsis

441

2462

1.55

16.37

1.7

1.9

13.10

12.65

mg/l

0.29

404

2287

Lung diseases due to external agents

238

1334

1.81

16.30

2.0

1.9

11.36

12.57

mg/l

1.13

223

1231

Leukaemia of unspecified cell type

5.09

16.26

1.5

2.3

16.21

12.75

mg/l

0.47

Generalized skin eruption due to drugs and medicaments

389

2.59

16.24

2.8

2.2

14.14

11.75

mg/l

1.00

358

Disorders of muscles

197

1045

1.92

16.15

2.6

2.1

11.87

11.45

mg/l

0.28

192

1000

Myocardial infarction, without ST-elevation

651

4154

1.43

16.06

1.9

14.31

12.21

mg/l

2.04

607

3848

Other/unspecified rheumatoid arthritis

224

1242

1.84

15.98

1.7

2.0

11.68

12.08

mg/l

0.34

205

1142

Endometriosis

581

2313

1.47

15.87

1.9

2.1

10.60

11.45

mg/l

1.97

533

2179

Psychiatric diseases

1816

7340

1.25

15.87

1.9

2.2

11.61

11.40

mg/l

0.30

1702

6918

Fracture of lumbar spine and pelvis

388

2484

1.58

15.81

1.8

1.9

12.74

12.27

mg/l

0.45

355

2281

Retinal detachments and breaks

620

4374

1.43

15.80

2.2

2.0

12.50

11.88

mg/l

0.95

575

4062

Polycystic ovarian syndrome, consortium definition

1284

5726

1.29

15.78

2.1

2.2

11.19

11.02

mg/l

0.25

1186

5377

Calculus of kidney and ureter

532

3652

1.47

15.74

2.3

2.0

12.02

12.01

mg/l

0.00

501

3421

Thyrotoxicosis

466

3117

1.51

15.73

2.5

2.1

11.83

11.43

mg/l

0.54

440

2907

IgA nephropathy (IgA glomerulonephritis)

232

3.08

15.62

1.7

2.4

17.91

11.41

mg/l

3.90

214

Injuries to the thorax

822

6082

1.36

15.59

2.1

12.23

11.79

mg/l

0.76

771

5684

Spirochaetal infections, other/unspecified

182

954

1.95

15.57

2.0

1.9

12.59

11.80

mg/l

0.28

166

892

Viral infections of the central nervous system

153

755

2.08

15.56

2.1

2.2

10.80

11.40

mg/l

0.39

137

706

Postmenopausal osteoporosis with pathological fracture

126

578

2.24

15.48

2.6

2.1

11.82

12.74

mg/l

0.56

105

535

Psoriasis

532

3665

1.47

15.48

1.9

2.1

11.29

11.74

mg/l

0.58

506

3425

Other chondrocalcinosis

110

4.20

15.47

2.0

2.3

13.42

mg/l

0.00

103

Etanercept

144

698

2.12

15.39

1.5

2.3

11.04

11.46

mg/l

0.24

136

659

Type 1 diabetes, wide definition, subgroup 1

366

2333

1.59

15.32

2.0

12.90

10.74

mg/l

3.92

345

2213

Sacroiliitis, not elsewhere classified

109

473

2.37

15.31

2.0

2.4

10.71

10.91

mg/l

0.10

104

453

Polyuria

391

2534

1.56

15.30

1.8

2.0

12.10

12.01

mg/l

0.07

361

2366

Unstable angina pectoris

555

3011

1.46

15.29

1.9

1.8

12.81

12.22

mg/l

0.75

521

2792

Other bursopathies

241

1387

1.77

15.15

2.6

2.1

10.94

11.76

mg/l

0.93

226

1308

Trigeminal neuralgia

123

565

2.24

15.08

2.1

10.06

11.93

mg/l

1.55

115

520

Abnormal blood-pressure reading, without diagnosis

354

2.58

15.08

1.7

2.1

11.96

12.24

mg/l

0.10

329

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

191

1028

1.90

15.06

2.0

13.91

11.88

mg/l

0.80

178

953

Irregular menses

876

4917

1.35

15.03

2.1

2.2

10.98

10.74

mg/l

0.29

825

4643

Pain associated with micturition

226

1289

1.78

14.70

1.9

2.1

11.62

11.73

mg/l

0.06

205

1200

COPD-related respiratory insufficiency

198

1085

1.86

14.70

2.0

1.8

12.74

12.88

mg/l

0.06

183

994

Injuries to the knee and lower leg

2195

9854

1.21

14.69

2.1

11.52

11.34

mg/l

0.49

2057

9264

Triptan medication for migraine, min. 3 purchases

1048

6025

1.31

14.64

2.3

2.2

10.87

10.78

mg/l

0.09

998

5692

Viral and other specified intestinal infections, including avohilmo

481

3156

1.48

14.63

2.1

11.21

10.90

mg/l

0.36

459

2981

Diseases of inner ear

971

7107

1.32

14.62

1.8

2.1

11.93

11.72

mg/l

0.15

907

6619

Elevated blood glucose level

163

841

1.98

14.61

2.3

2.1

11.91

11.54

mg/l

0.21

151

784

Nonorganic sleeping disorders, excluding more controls

374

2425

1.56

14.61

2.0

2.2

11.37

11.00

mg/l

0.39

346

2302

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

383

2040

1.56

14.60

1.7

1.9

11.86

11.99

mg/l

0.12

359

1897

Paralytic strabismus

139

679

2.10

14.56

1.9

2.0

11.89

11.71

mg/l

0.08

131

622

Primary adrenocortical insufficiency

102

4.23

14.50

2.3

2.4

8.01

12.37

mg/l

2.78

Abnormal findings on examination of urine, without diagnosis

417

2.43

14.46

1.9

2.2

15.26

11.94

mg/l

2.13

385

Propionic acid derivatives

441

1454

1.54

14.41

2.2

2.1

11.47

12.78

mg/l

1.95

408

1365

Dentofacial anomalies [including malocclusion]

1316

8175

1.27

14.37

2.0

2.2

10.19

11.14

mg/l

5.54

1238

7715

Tuberculosis of other organs

164

3.39

14.33

1.6

2.0

11.78

13.76

mg/l

0.95

150

Allergic contact dermatitis

249

1470

1.72

14.32

1.9

2.2

10.19

10.99

mg/l

1.06

229

1376

Multiple myeloma

205

3.09

14.31

1.1

2.0

15.13

12.84

mg/l

0.87

187

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

205

3.09

14.31

1.1

2.0

15.13

12.84

mg/l

0.87

187

Solid cancers, including Hilmo

1562

7335

1.25

14.27

2.1

2.2

11.45

11.07

mg/l

0.88

1468

6927

Anti-inflammatory and antirheumatic products, non-steroids

440

1454

1.53

14.24

2.2

2.1

11.23

12.78

mg/l

2.50

403

1365

Osteonecrosis

130

625

2.14

14.24

1.9

2.0

12.08

12.21

mg/l

0.06

125

583

Infective dermatitis

204

1140

1.82

14.23

1.9

2.0

10.87

11.40

mg/l

0.33

190

1057

Other specified/unspecified inflammatory spondylopathies

106

470

2.32

14.20

2.1

2.4

10.65

11.95

mg/l

0.79

101

445

Conductive and sensorineural hearing loss

1411

7491

1.26

14.13

2.0

2.1

12.02

11.62

mg/l

0.44

1313

7019

Osteomyelitis

127

607

2.15

14.10

2.5

2.0

15.47

12.07

mg/l

2.62

119

561

Urolithiasis

559

3957

1.43

14.06

2.2

2.0

12.05

12.04

mg/l

0.01

526

3701

Other shoulder lesions

181

979

1.88

14.05

2.0

2.2

10.86

11.22

mg/l

0.30

168

936

Brachial plexus disorders

188

1030

1.86

14.04

1.9

2.2

10.79

11.38

mg/l

0.48

182

972

Degenerative macular diseases

203

1140

1.81

13.94

1.8

1.9

12.42

12.32

mg/l

0.05

194

1043

Viral infections of the central nervous system, including avohilmo

159

828

1.97

13.92

2.1

2.2

10.64

11.31

mg/l

0.47

143

779

Other diseases of blood and blood-forming organs

134

657

2.09

13.91

2.1

15.77

12.17

mg/l

1.30

122

607

Type 1 diabetes

427

2875

1.50

13.88

2.0

13.59

10.88

mg/l

6.21

402

2717

Chronic nephritic syndrome

370

2.49

13.87

1.6

2.2

16.45

11.33

mg/l

3.62

339

Diabetic retinopathy, excluding more controls

520

2006

1.47

13.81

2.2

2.3

14.93

11.72

mg/l

2.89

485

1887

Spondylolisthesis/Spondylolysis

330

2110

1.59

13.79

2.2

11.15

11.84

mg/l

0.87

308

1977

External causes of morbidity and mortality

1173

4586

1.29

13.75

2.1

11.96

10.95

mg/l

1.25

1087

4360

Diseases of pulp and periapical tissues and dental caries

1127

4489

1.29

13.73

1.9

2.0

11.54

11.57

mg/l

0.03

1045

4208

Other disorders of veins

750

5500

1.35

13.71

2.1

12.22

11.41

mg/l

2.03

682

5143

Complications of internal orthopaedic prosthetic devices, implants and grafts

372

2447

1.54

13.66

2.0

1.9

12.57

12.14

mg/l

0.40

347

2272

Dermatographic urticaria

143

723

2.03

13.66

1.6

2.2

9.23

11.74

mg/l

3.30

137

684

Oter anti-inflammatory and antirheumatic agents, non-steroids

336

1158

1.61

13.60

2.1

12.22

13.15

mg/l

0.82

312

1089

Pleural plaque with presence of asbestos

124

596

2.13

13.57

1.6

1.7

11.12

13.38

mg/l

1.25

113

542

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

265

1617

1.67

13.49

1.9

2.0

13.64

11.85

mg/l

2.05

251

1515

Crohn disease

245

1466

1.70

13.45

1.7

2.1

11.63

11.03

mg/l

0.55

228

1386

Cerebrovascular diseases

1284

7093

1.26

13.43

1.8

2.1

12.69

11.72

mg/l

3.08

1188

6621

Lesion of ulnar nerve

261

1589

1.67

13.41

2.5

2.0

11.04

11.77

mg/l

0.76

248

1494

Lymphoid leukaemia

108

495

2.24

13.38

1.4

1.9

14.98

12.32

mg/l

0.69

103

458

Strabismus

462

3181

1.46

13.34

2.2

2.1

11.24

11.30

mg/l

0.05

436

2987

Other external causes of accidental injury

1455

5857

1.25

13.33

2.1

11.89

11.06

mg/l

1.37

1346

5548

L04AC Interleukin inhibitors

145

744

2.00

13.32

1.5

2.2

10.11

11.17

mg/l

1.09

139

705

Thyroiditis

146

751

1.99

13.29

2.3

2.1

11.29

11.64

mg/l

0.18

136

701

Degenerative diseases of the nervous system

259

3007

0.61

13.27

1.6

1.8

12.46

12.88

mg/l

0.33

228

2756

Haemorrhage, not elsewhere classified

282

2.66

13.19

1.4

1.9

15.67

12.12

mg/l

1.71

257

Other specified and unspecified retinal disorders

349

2.49

13.13

2.3

2.2

13.99

12.14

mg/l

0.74

324

Diabetic nephropathy

316

2001

1.59

13.13

2.0

2.2

16.78

12.72

mg/l

6.34

291

1865

Type 1 diabetes, wide definition

372

2467

1.52

13.08

2.1

2.0

12.91

10.78

mg/l

3.93

351

2337

Other hammer toe(s) (acquired)

265

1476

1.65

13.04

2.1

11.69

11.55

mg/l

0.10

237

1365

Lichen simplex chronicus

320

2.56

13.04

2.0

2.3

11.83

11.69

mg/l

0.05

300

Disorders of vestibular function (Vertigo)

826

6124

1.32

13.02

1.8

2.1

12.10

11.67

mg/l

0.28

769

5693

Otalgia

162

869

1.90

12.97

2.5

2.2

11.15

11.65

mg/l

0.32

145

821

Biological medicines for asthma

229

2.88

12.97

2.7

2.6

9.52

11.40

mg/l

2.03

215

Alzheimer disease

214

2569

0.59

12.92

1.6

1.7

12.74

13.07

mg/l

0.21

185

2339

Vascular disorders of the intestines

124

607

2.09

12.91

1.9

2.0

15.03

12.71

mg/l

1.27

116

556

Phlebitis and thrombophlebitis (not including DVT)

403

2732

1.49

12.85

2.2

2.1

12.22

11.75

mg/l

0.45

386

2555

Dermatophytosis

253

1547

1.66

12.81

2.1

2.0

12.32

11.68

mg/l

0.53

236

1440

Injuries to the wrist and hand

1861

10260

1.21

12.79

2.2

2.1

11.33

11.37

mg/l

0.05

1752

9642

Mouth breathing

701

5223

1.35

12.79

2.3

2.1

9.73

11.66

mg/l

9.22

660

4918

Gonarthrosis, primary, with knee surgery

983

5952

1.29

12.77

2.0

11.95

11.98

mg/l

0.04

924

5528

Other and unspecified disorders of vitreous body

749

5521

1.34

12.71

2.2

2.1

11.19

11.79

mg/l

1.29

699

5140

Alzheimer disease, including avohilmo

269

2951

0.63

12.70

1.8

12.58

13.00

mg/l

0.34

237

2695

Pneumonia due to Streptococcus pneumoniae

342

2.46

12.65

2.4

2.2

10.48

11.29

mg/l

0.37

319

Myeloproliferative diseases

152

806

1.93

12.64

1.8

2.0

15.57

12.33

mg/l

1.23

135

741

Solid cancers

1503

7171

1.23

12.63

2.1

2.2

11.49

11.10

mg/l

0.90

1413

6768

Panic disorder

263

1628

1.64

12.63

2.0

2.1

11.40

10.98

mg/l

0.20

244

1551

Peripheral artery disease

675

3943

1.36

12.60

1.8

14.84

12.03

mg/l

8.80

616

3660

Fenamates

231

925

1.72

12.60

2.3

2.2

10.95

12.78

mg/l

1.98

220

879

Generalized anxiety disorder

288

1821

1.60

12.57

2.0

2.1

11.11

10.88

mg/l

0.24

268

1727

Benign intracranial hypertension

4.33

12.55

1.6

2.1

12.30

10.53

mg/l

0.71

Fissure and fistula of anal and rectal regions

421

2892

1.47

12.53

2.2

2.1

11.65

11.54

mg/l

0.09

391

2723

Haemorrhoids and perianal venous thrombosis

577

4159

1.39

12.52

1.9

2.1

12.29

11.69

mg/l

0.60

539

3878

Other/unspecified enthesopathies of lower limb, excluding foot

146

767

1.94

12.49

2.4

2.2

11.53

11.81

mg/l

0.14

139

728

Peripheral arterial reconstruction

261

1617

1.64

12.49

1.7

1.8

15.04

12.93

mg/l

1.81

236

1490

Artificial joint operation, meniscal resection

1631

8589

1.22

12.41

2.1

11.53

11.63

mg/l

0.19

1533

8043

Other symptoms and signs involving cognitive functions and awareness

803

5426

1.32

12.39

1.9

2.0

12.13

11.96

mg/l

0.24

745

5054

Psoriasis vulgaris

339

2236

1.54

12.39

1.9

2.1

11.06

11.63

mg/l

0.62

320

2096

Tuberculosis of other organs, strict, including avohilmo

190

3.01

12.37

1.6

2.0

11.85

13.54

mg/l

0.79

174

Sensorineural hearing loss

1315

7067

1.25

12.35

2.0

2.1

11.96

11.70

mg/l

0.25

1225

6608

Diseases of external ear

621

4575

1.37

12.35

1.9

2.1

12.04

11.62

mg/l

0.40

560

4289

Tuberculosis of other organs, strict

185

3.04

12.32

1.6

2.0

11.85

13.65

mg/l

0.86

169

COPD, hospital admissions 1, only main diagnosis

540

3334

1.40

12.25

1.8

1.9

13.15

12.45

mg/l

0.64

497

3093

Seborrhoeic dermatitis

179

1009

1.81

12.22

1.8

2.0

9.74

11.56

mg/l

3.04

169

936

IBD patients in KELA-register

409

2809

1.47

12.22

1.8

2.1

11.37

10.99

mg/l

0.45

376

2656

Mucosal proctocolitis

238

1451

1.67

12.21

2.0

2.1

11.60

11.11

mg/l

0.44

223

1372

Hypocalcemia

231

2.81

12.19

2.1

2.4

15.55

11.88

mg/l

1.58

214

Unspecific neurodegenerative disorder

335

3439

0.66

12.18

1.7

1.8

12.13

12.99

mg/l

0.94

297

3153

Misadventures to patients during surgical and medical care

257

1598

1.63

12.18

2.3

2.0

12.97

11.50

mg/l

1.87

238

1499

Meningitis

108

515

2.16

12.18

2.3

11.19

11.54

mg/l

0.19

103

483

Acute lymphadenitis

120

595

2.07

12.16

2.0

2.3

12.70

10.93

mg/l

0.47

115

563

Unspecified privation

199

1160

1.75

12.11

1.9

2.1

13.49

11.46

mg/l

3.23

191

1082

Spontaneous rupture of synovium and tendon

150

804

1.90

12.07

1.6

2.0

13.00

11.68

mg/l

0.39

136

762

Viral warts, including avohilmo

387

2640

1.48

11.98

2.5

2.1

11.27

11.18

mg/l

0.08

361

2492

Atherosclerosis, excluding cerebral and coronary sclerosis

620

3586

1.37

11.93

1.8

14.66

12.15

mg/l

6.54

562

3319

Scoliosis

148

793

1.90

11.90

2.2

12.45

11.47

mg/l

0.84

140

749

Accidents

1438

5857

1.24

11.90

2.1

11.79

11.06

mg/l

1.12

1332

5548

Hallux valgus (acquired)

508

2583

1.42

11.90

2.2

11.71

11.22

mg/l

0.43

476

2420

Chronic hepatitis, not elsewhere classified

347

2.42

11.88

2.1

2.4

12.19

11.73

mg/l

0.21

322

Impingement syndrome of shoulder

402

2769

1.47

11.85

2.4

2.1

12.05

11.63

mg/l

0.61

371

2610

Special screening examination for other diseases and disorders

187

1075

1.76

11.84

1.9

2.1

9.92

11.16

mg/l

1.12

175

1020

Acute pharyngitis

257

1591

1.62

11.84

2.0

2.3

11.48

10.91

mg/l

0.53

240

1523

Covid-19 suspected case

380

2591

1.48

11.80

2.0

2.1

11.43

11.00

mg/l

0.55

364

2449

Menorrhagia

559

2241

1.40

11.78

2.1

10.92

11.52

mg/l

0.99

518

2111

Excessive attrition of teeth

1115

8839

1.26

11.76

2.1

2.2

11.05

11.17

mg/l

0.21

1038

8345

Retention of urine

549

3217

1.39

11.74

1.5

1.9

13.66

12.04

mg/l

1.10

511

3014

Diseases of middle ear and mastoid

1012

6531

1.27

11.69

2.1

11.14

11.28

mg/l

0.16

946

6155

Benign neoplasm of other and unspecified endocrine glands

245

1523

1.64

11.68

2.0

11.54

11.74

mg/l

0.13

223

1422

Visual field defects

153

835

1.87

11.66

1.7

1.9

11.82

11.92

mg/l

0.04

140

772

Behavioural syndromes associated with physiological disturbances and physical factors

1719

9692

1.21

11.66

2.0

2.2

10.96

11.40

mg/l

1.61

1600

9122

Other specified and unspecified disorders of eye and adnexa

356

2.38

11.65

2.7

2.4

12.38

11.92

mg/l

0.25

329

Pneumothorax

123

625

2.01

11.62

2.3

2.1

10.55

12.60

mg/l

1.41

115

576

Benign neoplasm of other and ill-defined parts of digestive system

316

2086

1.54

11.56

2.1

2.0

12.46

11.82

mg/l

0.77

300

1925

Falls/tendency to fall

1938

8149

1.20

11.55

2.1

11.60

11.16

mg/l

1.25

1808

7706

Benign neoplasm: Ascending colon

247

1543

1.63

11.53

2.0

1.9

13.64

12.20

mg/l

1.98

231

1424

Allergic urticaria

157

867

1.85

11.53

2.4

2.2

12.18

11.60

mg/l

0.35

146

817

Aortic aneurysm

354

2346

1.49

11.44

1.7

1.8

13.12

12.04

mg/l

0.37

329

2188

Autoimmune hyperthyroidism

111

547

2.07

11.43

2.4

2.3

10.27

12.16

mg/l

1.53

104

513

Alzheimer’s disease, strict definition

150

2151

0.56

11.40

1.5

1.7

13.89

13.06

mg/l

0.53

130

1949

Ankylosing spondylitis, ICD10

174

995

1.78

11.40

1.9

2.2

11.03

11.59

mg/l

0.40

164

935

Speech therapy

447

3169

1.43

11.30

1.9

2.1

12.12

11.80

mg/l

0.29

430

2955

Other specified/unspecified bacterial intestinal infections

125

646

1.98

11.29

1.9

2.1

12.09

11.96

mg/l

0.05

115

591

Periodontitis

1817

9723

1.20

11.26

1.9

2.2

12.27

11.29

mg/l

4.65

1686

9154

Allergic purpura

288

2.52

11.24

1.8

2.6

10.76

11.99

mg/l

0.64

267

Nummular dermatitis

148

809

1.86

11.24

2.0

11.42

11.54

mg/l

0.06

137

744

Injuries to the head

2023

10162

1.19

11.23

2.1

11.91

11.29

mg/l

1.36

1889

9573

Sixth [abducent] nerve palsy

319

2.43

11.20

1.8

2.2

11.90

12.30

mg/l

0.14

293

Malignant neoplasm of respiratory system and intrathoracic organs

327

1803

1.52

11.20

1.7

1.9

11.57

12.04

mg/l

0.52

309

1676

Cholangitis (primary sclerosing, PSC)

114

572

2.04

11.19

1.8

2.0

12.52

11.97

mg/l

0.24

106

532

Heartburn

203

1217

1.69

11.15

2.2

1.9

10.95

11.44

mg/l

0.41

180

1146

Chronic periodontitis, including avohilmo

1813

9721

1.19

11.14

1.9

2.2

12.31

11.29

mg/l

4.97

1682

9153

Abnormalities of gait and mobility

203

1218

1.69

11.13

1.6

1.9

11.99

12.41

mg/l

0.29

187

1114

Bronchitis, not specified as acute or chronic

146

798

1.86

11.07

2.3

2.1

11.42

12.53

mg/l

0.70

138

742

L01XE Protein kinase inhibitors

104

508

2.10

11.06

1.5

2.1

11.05

12.19

mg/l

0.56

473

Other and unspecified nerve root and plexus disorders, also in other diseases

369

2537

1.47

11.04

2.3

2.1

11.27

11.63

mg/l

0.41

346

2374

Synovial cyst of popliteal space [Baker]

132

700

1.92

11.03

2.5

2.0

10.22

11.90

mg/l

1.95

122

658

Atopic dermatitis, strict definition

506

3596

1.39

10.97

2.0

2.2

11.26

10.71

mg/l

0.48

477

3409

Diabetic maculopathy, excluding more controls

185

1087

1.73

10.96

2.1

1.9

13.54

11.12

mg/l

2.38

175

1014

200

2.81

10.74

2.5

2.0

13.18

13.20

mg/l

0.01

181

Other follicular disorders

150

836

1.83

10.74

1.8

2.2

10.73

10.80

mg/l

0.04

142

785

Inflammatory bowel disease, strict (require KELA)

409

2885

1.43

10.66

1.8

2.1

11.37

11.14

mg/l

0.23

376

2729

Injury, poisoning and certain other consequences of external causes

938

3690

1.28

10.64

2.1

12.14

10.92

mg/l

1.21

867

3495

Other sleep disorders

196

1180

1.69

10.62

2.1

2.0

10.59

11.62

mg/l

1.16

185

1112

Use of anticholinesterases

258

3047

0.65

10.60

1.6

1.8

11.59

12.99

mg/l

1.69

230

2776

N06DA Anticholinesterases

258

3047

0.65

10.60

1.6

1.8

11.59

12.99

mg/l

1.69

230

2776

Restless leg syndrome

262

1698

1.57

10.49

1.9

2.1

11.34

11.84

mg/l

0.44

243

1585

Personal history of allergy to drugs, medicaments and biological substances

107

3.56

10.49

2.1

2.2

9.64

10.54

mg/l

0.42

101

Thoracic aortic aneurysm

243

1550

1.59

10.43

1.7

1.9

11.87

11.72

mg/l

0.11

226

1449

Primary gonarthrosis, bilateral

866

5711

1.28

10.41

1.9

2.1

12.27

11.92

mg/l

0.56

814

5302

Other/unspecified enthesopathies, not elsewhere classified

145

807

1.83

10.41

2.2

11.31

11.58

mg/l

0.13

137

765

Endometriosis of pelvic peritoneum

280

1672

1.54

10.37

2.0

2.2

10.11

11.19

mg/l

2.10

256

1585

MS-disease / Multiple Sclerosis

144

802

1.83

10.36

1.6

2.2

9.68

11.12

mg/l

1.83

139

761

Umbilical hernia

479

3496

1.38

10.24

2.2

2.0

12.24

11.55

mg/l

1.00

454

3284

Ascites

129

697

1.89

10.21

1.9

14.37

12.18

mg/l

1.47

117

647

Speech disturbances, not elsewhere classified

153

872

1.78

10.16

1.7

1.9

11.55

12.24

mg/l

0.46

141

802

Other and unspecified myopathies

149

843

1.80

10.15

2.0

13.00

12.01

mg/l

0.50

140

774

Appendectomy

1157

9009

1.23

10.06

2.3

2.2

11.15

11.18

mg/l

0.04

1105

8479

Sleep disorders

1643

9527

1.19

10.05

2.0

2.2

10.98

11.41

mg/l

1.45

1528

8967

Other abnormal uterine and vaginal bleeding

379

1899

1.45

10.03

2.2

2.1

11.91

11.76

mg/l

0.12

337

1779

Caries of enamel

1754

9714

1.19

10.01

2.3

2.1

11.63

11.20

mg/l

1.62

1643

9157

Glaucoma suspect

601

4552

1.33

10.00

2.4

2.0

11.39

12.00

mg/l

1.01

561

4210

Benign thyroid growths and nodules

534

3692

1.35

9.97

1.9

2.1

11.69

mg/l

0.00

494

3409

Dental pulpitis, including avohilmo

1684

9101

1.19

9.95

2.0

2.2

10.75

11.20

mg/l

1.64

1584

8600

Hernia of abdominal wall

776

6089

1.28

9.92

2.1

12.96

11.63

mg/l

1.38

733

5696

Amputation

159

922

1.75

9.91

1.9

1.8

16.25

12.40

mg/l

3.24

148

841

Persons with potential health hazards related to communicable diseases

632

4795

1.32

9.74

2.1

10.47

11.00

mg/l

0.88

597

4535

Respiratory tuberculosis, confirmed, including avohilmo

138

3.08

9.71

1.4

2.1

13.20

13.27

mg/l

0.01

123

Diseases of appendix

1319

9798

1.21

9.71

2.3

2.1

11.22

11.27

mg/l

0.09

1254

9220

Injuries to the shoulder and upper arm

1525

9893

1.19

9.65

2.1

11.29

11.56

mg/l

0.66

1416

9301

Artificial joint re-operation

124

675

1.88

9.65

2.1

13.42

12.56

mg/l

0.53

117

620

Other local infections of skin and subcutaneous tissue

182

1105

1.67

9.62

2.1

13.46

11.56

mg/l

1.61

173

1029

638

4403

1.31

9.57

2.0

1.9

12.33

12.56

mg/l

0.27

598

4049

Ganglion

343

2392

1.45

9.56

2.2

11.09

11.20

mg/l

0.11

326

2268

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

283

1907

1.50

9.47

2.0

2.1

11.46

11.23

mg/l

0.19

263

1802

Familial hypercholesterolemia

220

1403

1.59

9.47

1.7

1.8

13.16

12.03

mg/l

0.86

205

1297

Appendicitis, broad definition

1307

9761

1.21

9.46

2.3

2.1

11.21

11.27

mg/l

0.10

1244

9184

Drug-induced neutropenia

133

745

1.82

9.45

1.6

2.1

11.46

12.10

mg/l

0.12

128

690

Viral warts

176

1065

1.68

9.43

3.2

2.1

12.43

11.21

mg/l

1.00

167

998

Intestinal malabsorption

491

2.03

9.42

2.0

2.3

12.00

11.90

mg/l

0.04

459

Acute gastritis

126

694

1.85

9.42

1.6

2.0

11.28

11.84

mg/l

0.34

118

635

Neuralgia and neuritis, unspecified

498

2.01

9.38

2.1

2.2

12.04

11.34

mg/l

0.38

472

Disorders of refraction and accommodation

485

3584

1.36

9.36

2.3

2.1

10.60

11.19

mg/l

1.00

448

3379

Nonsuppurative otitis media, including avohilmo

523

3383

1.35

9.33

2.0

11.26

11.12

mg/l

0.13

495

3199

Respiratory tuberculosis, confirmed

136

3.05

9.33

1.4

2.1

13.15

13.26

mg/l

0.02

121

Malignant neoplasm of bronchus and lung, including Hilmo

314

1797

1.47

9.29

1.7

1.9

12.11

12.04

mg/l

0.05

293

1669

Alzheimer’s disease (Late onset)

141

1976

0.58

9.26

1.5

1.7

14.13

13.20

mg/l

0.57

121

1779

Other diseases of oesophagus

153

896

1.73

9.26

2.1

2.0

12.26

12.58

mg/l

0.14

140

831

Superficial injury of lower leg

448

3290

1.37

9.25

2.0

2.1

11.23

11.33

mg/l

0.10

416

3087

Pleural plaque without asbestos

283

2.36

9.24

1.6

1.9

12.81

12.88

mg/l

0.02

254

Vitreous haemorrhage

174

1056

1.67

9.24

1.9

2.0

14.51

11.76

mg/l

2.20

166

975

Nonsuppurative otitis media

360

2205

1.43

9.19

2.0

1.9

11.32

11.03

mg/l

0.23

338

2085

Atrophic disorders of skin

275

1855

1.50

9.18

2.6

2.1

11.24

11.44

mg/l

0.18

261

1718

Achilles tendinitis

186

1150

1.64

9.17

2.4

2.1

11.45

11.91

mg/l

0.34

177

1088

Use of memantine

183

2349

0.62

9.17

1.6

1.7

12.41

13.15

mg/l

0.52

159

2128

Use of other anti-dementia drugs

183

2349

0.62

9.17

1.6

1.7

12.41

13.15

mg/l

0.52

159

2128

Other and unspecified local infections of skin and subcutaneous tissue

173

1051

1.67

9.15

2.2

2.1

13.28

11.53

mg/l

1.34

165

981

Benign neoplasm: Colon, unspecified

409

2967

1.39

9.14

2.1

2.0

12.68

12.32

mg/l

0.38

379

2763

Other dialysis

292

2.34

9.10

1.8

2.3

22.53

11.75

mg/l

5.80

273

Peripheral artery operations in Hilmo

187

1159

1.63

9.07

1.9

1.8

15.84

12.18

mg/l

3.92

173

1062

Abnormal involuntary movements

229

1492

1.56

9.02

1.7

2.1

12.36

12.02

mg/l

0.26

207

1388

Cholecystitis

224

1452

1.56

9.00

2.2

1.9

13.84

11.80

mg/l

1.14

208

1345

Nail disorders

156

927

1.71

9.00

2.4

2.2

12.54

11.47

mg/l

0.77

150

862

Acute appendicitis, no complications

981

7946

1.23

8.99

2.3

2.2

11.12

11.14

mg/l

0.02

939

7497

Other extrapyramidal and movement disorders in other diseases

418

3052

1.38

8.99

1.9

2.1

11.40

12.08

mg/l

0.93

387

2837

Benign neoplasm: Transverse colon

184

1141

1.64

8.99

2.8

1.9

14.36

11.94

mg/l

3.46

172

1049

Dislocation, sprain and strain of joints and ligaments at neck level

271

1831

1.50

8.98

1.8

2.1

10.66

11.17

mg/l

0.57

254

1736

Use of pramipexole

365

2607

1.41

8.97

2.2

2.0

11.95

12.17

mg/l

0.18

338

2413

Paralytic ileus and intestinal obstruction

401

2905

1.39

8.96

1.7

2.0

12.22

12.06

mg/l

0.13

362

2711

Tuberculosis

485

1.99

8.95

1.7

2.0

11.78

13.57

mg/l

0.71

441

Epilepsy

463

3423

1.36

8.95

2.0

11.95

11.60

mg/l

0.25

425

3216

Myeloproliferative diseases (CML excluded)

129

728

1.81

8.94

1.9

2.0

15.74

12.31

mg/l

1.12

114

670

Open wound of lower leg

255

1703

1.51

8.94

2.3

2.1

12.45

11.70

mg/l

0.67

236

1590

Chondropathies

262

1761

1.51

8.92

1.9

2.1

10.88

11.35

mg/l

0.47

250

1661

Nonorganic sleeping disorders

374

2685

1.41

8.91

2.0

2.1

11.37

11.11

mg/l

0.25

346

2539

Other and unspecified follicular disorders

427

2.07

8.84

2.1

2.2

9.97

11.47

mg/l

1.05

396

Essential (haemorrhagic) thrombocythaemia

321

2.24

8.83

1.8

2.1

16.63

12.10

mg/l

0.76

296

Charcot foot

141

2.95

8.78

2.8

1.9

18.94

11.08

mg/l

2.28

129

Unspecified/other endometriosis

162

957

1.68

8.78

2.2

10.39

10.96

mg/l

0.47

152

917

Haemophagocytic lymphohistiocytosis

18.80

8.77

2.2

1.9

11.52

8.83

mg/l

—

Haemolytic anaemias

303

2.27

8.75

2.6

2.3

12.17

12.27

mg/l

0.03

284

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

305

2120

1.45

8.74

1.9

2.1

11.44

11.24

mg/l

0.17

282

2002

Any death

1067

6127

1.22

8.71

1.7

2.1

13.08

11.69

mg/l

3.57

971

5741

Special screening examination for neoplasms

106

567

1.90

8.71

2.1

2.0

13.14

11.24

mg/l

1.53

536

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

316

2212

1.44

8.71

2.5

2.1

11.16

11.10

mg/l

0.04

298

2090

Trigger finger

241

1600

1.52

8.70

2.0

2.2

11.02

11.44

mg/l

0.38

232

1516

Enteropathic arthropathies

193

2.62

8.69

1.6

2.8

9.89

10.59

mg/l

0.25

183

Retinal vascular occlusion

181

1128

1.63

8.65

2.1

1.9

12.51

12.40

mg/l

0.06

163

1027

Any dementia

327

3185

0.70

8.64

1.5

1.8

12.52

12.86

mg/l

0.27

289

2917

Necrosis of pulp, including avohilmo

1053

8577

1.22

8.63

2.0

2.2

10.87

11.12

mg/l

0.55

979

8102

Retinal vascular disorders

183

1144

1.62

8.63

2.1

1.9

12.55

12.47

mg/l

0.04

165

1040

Hordeolum and other deep inflammation of eyelid

109

591

1.88

8.62

2.2

11.72

11.79

mg/l

0.03

556

Combined immunodeficiencies

3.85

8.59

3.2

1.2

11.08

10.88

mg/l

0.05

Ulcerative colitis (strict definition, require KELA)

286

1972

1.47

8.57

2.0

2.1

11.45

11.25

mg/l

0.17

266

1861

Other disorders of cornea

166

1017

1.66

8.53

2.2

2.0

11.23

11.97

mg/l

0.67

159

929

Infections with a predominantly sexual mode of transmission

516

3913

1.33

8.49

2.5

2.2

11.67

10.82

mg/l

2.18

488

3706

Benign neoplasm: Stomach

164

1004

1.66

8.47

2.0

12.84

12.27

mg/l

0.44

157

926

Fibroblastic disorders

358

2574

1.40

8.46

2.0

12.15

12.01

mg/l

0.11

331

2411

Respiratory tuberculosis, bacteriologically and histologically confirmed

144

2.87

8.45

1.4

2.1

13.15

13.19

mg/l

0.01

129

Stenosis and insufficiency of lacrimal passages

152

913

1.69

8.43

2.3

2.0

11.11

12.12

mg/l

0.79

140

848

Persistent mood disorders

317

2234

1.43

8.43

2.0

2.2

12.41

11.41

mg/l

1.43

296

2103

Injuries to the ankle and foot

1293

9282

1.19

8.42

2.2

11.56

11.14

mg/l

1.14

1207

8765

Adhesive capsulitis of shoulder

267

1823

1.48

8.41

2.0

2.1

12.09

11.72

mg/l

0.28

252

1722

Ulcerative enterocolitis

309

2.23

8.38

1.9

2.3

10.87

11.43

mg/l

0.23

289

Intracranial injury

990

7575

1.22

8.37

2.1

2.0

11.34

11.54

mg/l

0.25

915

7105

Hepatic failure, not elsewhere classified

369

2.12

8.33

2.4

2.3

12.34

12.05

mg/l

0.10

339

Arterial embolism and thrombosis

470

1.97

8.32

1.7

2.0

12.19

12.04

mg/l

0.05

429

Acute appendicitis

1220

9488

1.20

8.32

2.3

2.2

11.26

11.23

mg/l

0.05

1164

8933

Other peripheral vertigo

156

948

1.67

8.30

1.9

2.0

11.51

12.06

mg/l

0.39

146

870

Extreme obesity with alveolar hypoventilation

417

2.04

8.29

2.1

2.2

12.54

11.70

mg/l

0.33

386

Non-small cell lung cancer, including Hilmo

217

1333

1.54

8.28

1.9

11.94

12.12

mg/l

0.12

206

1229

Viral and other specified intestinal infections

315

2168

1.43

8.28

2.0

2.1

11.11

10.98

mg/l

0.10

298

2046

Fracture of rib(s), sternum and thoracic spine

503

3826

1.32

8.26

2.0

12.59

11.95

mg/l

0.85

468

3570

Insomnia

1599

9512

1.17

8.26

2.0

2.2

10.83

11.35

mg/l

2.03

1488

8952

Benign neoplasm of mouth and pharynx

180

1136

1.61

8.22

2.0

12.33

11.64

mg/l

0.57

165

1057

Bipolar affective disorders

308

2172

1.43

8.17

2.0

2.2

11.30

10.81

mg/l

0.58

285

2067

Cerebral palsy and other paralytic syndromes

182

1153

1.60

8.16

2.0

12.51

11.93

mg/l

0.33

174

1072

Cervicocranial syndrome

183

1162

1.60

8.13

2.3

2.1

11.01

11.97

mg/l

0.83

172

1089

Congenital malformations, deformations and chromosomal abnormalities

1013

7932

1.22

8.11

1.9

2.2

11.50

11.09

mg/l

0.92

955

7478

Flat foot [pes planus] (acquired)

153

931

1.67

8.08

2.4

2.2

10.78

10.82

mg/l

0.02

146

872

Other localized connective tissue disorders

201

2.54

8.06

2.4

2.3

12.43

11.78

mg/l

0.16

188

Benign neoplasm: Caecum

178

1126

1.60

8.06

1.9

2.0

13.45

12.21

mg/l

1.17

165

1037

Other symptoms and signs involving the urinary system

166

1032

1.63

8.06

1.7

1.9

9.68

11.80

mg/l

3.23

160

957

Dementia in Alzheimer disease

1467

0.55

8.04

1.5

1.7

12.29

13.05

mg/l

0.32

1324

Benign paroxysmal vertigo

483

3669

1.33

8.04

1.7

2.0

11.97

11.77

mg/l

0.13

446

3400

Anaemia in chronic diseases classified elsewhere

207

2.49

8.03

1.6

2.0

16.78

12.02

mg/l

1.61

189

Hyperplasia of prostate

566

2445

1.31

8.02

1.9

2.0

12.94

11.94

mg/l

0.60

527

2313

Other blood glucose lowering drugs, excl. Insulins

240

1622

1.50

7.99

2.1

1.8

11.71

11.83

mg/l

0.08

227

1502

Crohn's disease NAS

120

687

1.78

7.98

1.7

2.3

12.30

11.08

mg/l

0.78

105

648

KRA_PSY_EATING, excluding more controls

121

687

1.77

7.93

1.8

2.3

10.52

10.21

mg/l

0.22

113

655

Non-allergic asthma

140

837

1.70

7.91

1.7

2.1

11.33

11.59

mg/l

0.15

134

779

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1120

8531

1.20

7.85

1.9

2.2

11.48

11.09

mg/l

0.93

1056

8041

Tubulo-interstitial nephritis, not specified as acute or chronic

104

574

1.84

7.79

1.9

13.37

11.10

mg/l

1.08

529

Diseases of peritoneum

164

1026

1.62

7.79

1.9

14.06

12.32

mg/l

1.13

157

945

Benign neoplasm: Sigmoid colon

305

2168

1.42

7.79

2.3

1.9

13.77

12.27

mg/l

2.28

287

2014

Blepharochalasis

452

3418

1.33

7.78

1.9

2.0

11.80

12.06

mg/l

0.26

422

3161

Other disorders of the musculoskeletal system and connective tissue

245

1675

1.48

7.74

1.6

2.0

11.30

11.78

mg/l

0.45

232

1560

Diabetic retinopathy

621

3017

1.29

7.74

2.1

2.3

14.65

12.38

mg/l

2.10

574

2818

Pneumonia derived septicemia

306

2.18

7.73

2.7

2.1

11.02

12.21

mg/l

0.56

280

Actinic keratosis

569

4033

1.29

7.71

2.0

1.8

12.26

12.68

mg/l

0.54

531

3701

Combinations of oral blood glucose lowering drugs

458

3475

1.33

7.71

2.0

13.37

11.64

mg/l

1.02

435

3266

Gluteal tendinitis

435

1.97

7.71

2.6

2.3

10.46

12.39

mg/l

1.28

407

Striking against or struck by other objects

566

4410

1.29

7.69

2.2

2.1

11.99

11.27

mg/l

1.59

528

4169

Diseases of male genital organs

825

3347

1.25

7.69

1.9

2.1

12.39

11.54

mg/l

0.77

775

3178

Plantar fascial fibromatosis

168

1061

1.61

7.67

2.1

2.2

11.51

11.28

mg/l

0.18

153

1010

Later onset COPD

391

2318

1.36

7.65

1.5

1.8

13.15

13.14

mg/l

0.01

357

2127

Injuries to the neck

385

2851

1.36

7.65

2.0

2.1

11.18

11.25

mg/l

0.07

364

2691

Vitamin B12 deficiency anaemia

153

945

1.64

7.64

1.6

1.9

14.79

12.65

mg/l

0.73

135

870

Convalescence

536

1.86

7.61

2.1

2.0

10.94

11.56

mg/l

0.33

497

Suppurative and unspecified otitis media

584

4050

1.28

7.59

2.1

10.97

10.98

mg/l

0.01

546

3837

Cyst of kidney

121

705

1.75

7.59

2.5

2.0

12.44

11.92

mg/l

0.35

114

647

Carbimazole or st.post thyroidectomy, condition for graves disease

356

2609

1.38

7.58

2.5

2.1

11.49

11.40

mg/l

0.09

337

2443

Malignant neoplasm of bronchus and lung

265

1537

1.45

7.52

1.7

1.9

11.81

12.07

mg/l

0.22

250

1426

Amenorrhoea

112

640

1.78

7.49

1.7

2.0

9.80

11.07

mg/l

1.22

106

614

Acne

170

1078

1.59

7.44

1.9

2.2

10.14

10.44

mg/l

0.21

163

1030

Impacted cerumen

181

1172

1.56

7.43

1.9

2.0

11.83

12.07

mg/l

0.15

153

1085

Otitis externa, unspecified

192

1260

1.54

7.42

1.9

2.2

11.46

11.19

mg/l

0.19

179

1182

L01XX Other antineoplastic agents

549

1.84

7.37

2.0

17.68

12.44

mg/l

1.50

501

Ptosis of eyelid

175

1127

1.57

7.37

2.5

2.0

12.73

12.38

mg/l

0.24

165

1044

Acute pancreatitis

315

2276

1.40

7.33

1.9

2.0

11.97

11.76

mg/l

0.15

290

2138

Skin changes due to chronic exposure to nonionizing radiation

583

4155

1.28

7.30

2.0

1.8

12.27

12.61

mg/l

0.45

545

3817

Acute suppurative otitis media

419

2947

1.33

7.26

2.2

2.1

10.95

10.81

mg/l

0.14

394

2804

Viral meningitis

376

2.02

7.22

2.0

2.2

9.77

10.76

mg/l

0.57

354

Postzoster neuralgia

134

2.79

7.21

1.8

2.2

11.53

13.10

mg/l

0.50

123

Other noninflammatory disorders of vagina

133

806

1.67

7.21

2.2

2.1

11.26

11.81

mg/l

0.39

120

760

Hallux rigidus

202

1350

1.51

7.16

2.3

2.1

11.74

11.19

mg/l

0.59

193

1256

Intracranial and intraspinal abscess and granuloma

124

2.89

7.14

1.6

2.4

13.92

12.37

mg/l

0.44

118

Viral meningitis, including avohilmo

392

1.99

7.11

2.0

2.3

9.63

10.81

mg/l

0.74

369

Unspecified fall

837

6759

1.22

7.09

2.0

12.01

11.69

mg/l

0.57

775

6315

Other disorders of nervous system

115

674

1.74

7.09

2.1

2.0

11.97

12.16

mg/l

0.07

108

624

Faecal incontinence

149

934

1.62

7.06

2.1

2.0

11.38

12.08

mg/l

0.46

128

873

Persons encountering health services for specific procedures, not carried out

147

919

1.62

7.05

2.0

13.91

11.13

mg/l

3.06

141

858

Hyperkinetic disorders, excluding more controls

192

1186

1.52

7.03

1.8

2.2

9.79

10.43

mg/l

0.78

176

1137

Systemic disorders of connective tissue in diseases classified elsewhere

6.73

7.02

3.3

1.9

13.46

11.26

mg/l

0.54

Problems related to lifestyle

175

1141

1.55

6.99

1.7

2.1

11.22

11.35

mg/l

0.08

162

1083

Hydronephrosis

166

1071

1.57

6.94

2.0

1.8

12.96

11.03

mg/l

1.63

155

988

Respiratory tuberculosis, confirmed and not-confirmed

430

1.92

6.92

1.8

2.1

11.87

13.64

mg/l

0.61

396

Respiratory tuberculosis

430

1.92

6.92

1.8

2.1

11.87

13.64

mg/l

0.61

396

Other ulcerative colitis

106

612

1.76

6.92

2.2

2.3

11.63

11.13

mg/l

0.25

575

Benign neoplasm of eye and adnexa

170

1105

1.56

6.91

2.4

2.0

11.39

11.96

mg/l

0.52

155

1023

Other or unspecified ileus, impaction or obstruction

276

1970

1.41

6.90

1.7

1.9

12.22

12.31

mg/l

0.05

248

1836

Other and unspecified glaucoma

110

642

1.74

6.88

1.9

11.05

12.52

mg/l

1.10

102

585

Primary open-angle glaucoma

461

3421

1.30

6.87

2.0

1.8

11.40

12.63

mg/l

2.11

421

3134

Tinnitus

395

2988

1.33

6.87

2.3

2.1

10.44

11.69

mg/l

2.80

364

2804

420

2743

1.32

6.86

2.0

1.8

13.29

12.84

mg/l

0.15

382

2501

Diseases of tongue

102

584

1.77

6.82

2.0

2.2

11.73

11.89

mg/l

0.08

535

Crohn's disease of small intestine

124

750

1.68

6.82

1.6

2.3

11.61

11.08

mg/l

0.32

115

708

Drug-induced systemic lupus erythematosus

3.80

6.75

1.8

2.1

14.90

11.31

mg/l

1.22

DVT of lower extremities

289

2089

1.40

6.75

2.2

2.0

12.71

12.08

mg/l

0.49

267

1946

Malignant neoplasm of endocrine gland, including Hilmo

134

831

1.64

6.67

2.3

2.2

12.07

11.29

mg/l

0.45

124

771

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lysozyme [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS